Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

References

  1. Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996;17(1):53-80.(s).
  2. Harris AD, Bradham DD, Baumgarten M, Zuckerman IH, Fink JC, Perencevich EN. The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis 2004;38(11):1586-91.
  3. Morton V, Torgerson DJ. Effect of regression to the mean on decision making in health care. Bmj 2003;326(7398):1083-4.
  4. Pocock SJ, Elbourne DR. Randomized trials or observational tribulations? N Engl J Med 2000;342(25):1907-9.
  5. Ioannidis JP, Haidich AB, Pappa M, et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. Jama 2001;286(7):821-30.
  6. Bent S, Shojania KG, Saint S. The use of systematic reviews and metaanalyses in infection control and hospital epidemiology. Am J Infect Control 2004;32(4):246-54.
  7. Harris AD, Lautenbach E, Perencevich E. A systematic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance. Clin Infect Dis 2005;41(1):77-82.
  8. Evans R, Lloyd JF, Abouzelof RH, Taylor CW, Anderson VR, Samore MH. System-wide Surveillance for Clinical Encounters by Patients Previously Identified with MRSA and VRE. Medinfo 2004;2004:212-6.
  9. Srinivasan A, McDonald LC, Jernigan D, et al. Foundations of the severe acute respiratory syndrome preparedness and response plan for healthcare facilities. Infect Control Hosp Epidemiol 2004;25(12):1020-5.
  10. www.cdc.gov/flu/avian/professional/infect-control.htm
  11. CDC. Guidelines for Environmental Infection Control in Health-Care Facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR 2003;52(RR10);1-42.
  12. CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005;54(17):1-141.
  13. AIA. Guidelines for Design and Construction of Hospital and Health Care Facilities. In: American Institute of Architects. Washington, DC: American Institute of Architects Press; 2006.
  14. CDC. Guidelines for Preventing Health-Care-Associated Pneumonia, 2003. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004;53(RR-3):140.
  15. CDC. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR - Morbidity & Mortality Weekly Report 2000;49(RR-10):1-125.
  16. Boyce JM, Pittet D. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep 2002;51(RR-16):1-45, quiz CE1-4.
  17. Bolyard EA, Tablan OC, Williams WW, Pearson ML, Shapiro CN, Deitchmann SD. Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1998;19(6):407-63.
  18. CDC. Recommendations for Preventing Transmission of Infections Among Chronic Hemodialysis Patients. MMWR 2001;50(RR05):1-43.
  19. Kohn WG, Collins AS, Cleveland JL, Harte JA, Eklund KJ, Malvitz DM. Guidelines for infection control in dental health-care settings--2003. MMWR Recomm Rep 2003;52(RR-17):1-61.
  20. Saiman L, Siegel J. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol 2003;24(5 Suppl):S6-52.
  21. Varia M, Wilson S, Sarwal S, et al. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. Cmaj 2003;169(4):285-92.
  22. Haley RW, Cushion NB, Tenover FC, et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 1995;171(3):614-24.
  23. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect Dis 2003;37(8):1094-101.
  24. Hall CB. Nosocomial respiratory syncytial virus infections: the "Cold War" has not ended. Clin Infect Dis 2000;31(2):590-6.
  25. Campbell JR, Zaccaria E, Mason EO, Jr., Baker CJ. Epidemiological analysis defining concurrent outbreaks of Serratia marcescens and methicillin-resistant Staphylococcus aureus in a neonatal intensive-care unit. Infect Control Hosp Epidemiol 1998;19(12):924-8.
  26. Pena C, Pujol M, Ardanuy C, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1998;42(1):538.
  27. Bonten MJ, Slaughter S, Ambergen AW, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998;158(10):1127-32.
  28. Jensenius M, Ringertz SH, Berild D, Bell H, Espinoza R, Grinde B. Prolonged nosocomial outbreak of hepatitis A arising from an alcoholic with pneumonia. Scand J Infect Dis 1998;30(2):119-23.
  29. Zawacki A, O'Rourke E, Potter-Bynoe G, Macone A, Harbarth S, Goldmann D. An outbreak of Pseudomonas aeruginosa pneumonia and bloodstream infection associated with intermittent otitis externa in a healthcare worker. Infect Control Hosp Epidemiol 2004;25(12):1083-9.
  30. Foca M, Jakob K, Whittier S, et al. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. N Engl J Med 2000;343(10):695-700.
  31. Gupta A, Della-Latta P, Todd B, et al. Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit linked to artificial nails. Infect Control Hosp Epidemiol 2004;25(3):210-5.
  32. Boyce JM, Opal SM, Potter-Bynoe G, Medeiros AA. Spread of methicillin-resistant Staphylococcus aureus in a hospital after exposure to a health care worker with chronic sinusitis. Clin Infect Dis 1993;17(3):496-504.
  33. Fliegel PE, Weinstein WM. Rubella outbreak in a prenatal clinic: management and prevention. Am J Infect Control 1982;10(1):29-33.
  34. Atkinson WL, Markowitz LE, Adams NC, Seastrom GR. Transmission of measles in medical settings--United States, 1985-1989. Am J Med 1991;91(3B):320S-4S.
  35. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000;355(9198):93-7.
  36. CDC. Outbreaks of pertussis associated with hospitals--Kentucky, Pennsylvania, and Oregon, 2003. MMWR Morb Mortal Wkly Rep 2005;54(3):67-71.
  37. Mermel LA, McKay M, Dempsey J, Parenteau S. Pseudomonas surgical-site infections linked to a healthcare worker with onychomycosis. Infect Control Hosp Epidemiol 2003;24(10):749-52.
  38. Barnes GL, Callaghan SL, Kirkwood CD, Bogdanovic-Sakran N, Johnston LJ, Bishop RF. Excretion of serotype G1 rotavirus strains by asymptomatic staff: a possible source of nosocomial infection. J Pediatr 2003;142(6):722-5.
  39. Wang JT, Chang SC, Ko WJ, et al. A hospital-acquired outbreak of methicillin-resistant Staphylococcus aureus infection initiated by a surgeon carrier. J Hosp Infect 2001;47(2):104-9.
  40. Valenti WM, Pincus PH, Messner MK. Nosocomial pertussis: possible spread by a hospital visitor. Am J Dis Child 1980;134(5):520-1.
  41. Christie CD, Glover AM, Willke MJ, Marx ML, Reising SF, Hutchinson NM. Containment of pertussis in the regional pediatric hospital during the Greater Cincinnati epidemic of 1993. Infect Control Hosp Epidemiol 1995;16(10):556-63.
  42. Munoz FM, Ong LT, Seavy D, Medina D, Correa A, Starke JR. Tuberculosis among adult visitors of children with suspected tuberculosis and employees at a children's hospital. Infect Control Hosp Epidemiol 2002;23(10):568-72.
  43. Garcia R, Raad I, Abi-Said D, et al. Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients. Infect Control Hosp Epidemiol 1997;18(6):412-6.
  44. Whimbey E, Champlin RE, Couch RB, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996;22(5):778-82.
  45. Saiman L, O'keefe M, Graham PL, et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 2003;37(10):1313-9.
  46. Bonten MJ, Slaughter S, Hayden MK, Nathan C, van Voorhis J, Weinstein RA. External sources of vancomycin-resistant enterococci for intensive care units. Crit Care Med 1998;26(12):2001-4.
  47. Flynn DM, Weinstein RA, Nathan C, Gaston MA, Kabins SA. Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery. J Infect Dis 1987;156(2):363-8.
  48. Olson B, Weinstein RA, Nathan C, Chamberlin W, Kabins SA. Epidemiology of endemic Pseudomonas aeruginosa: why infection control efforts have failed. J Infect Dis 1984;150(6):808-16.
  49. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002;346(24):1871-7.
  50. Toltzis P, Hoyen C, et al. Factors that predict preexisting colonization with antibiotic-resistant gram-negative bacilli in patients admitted to a pediatric intensive care unit. Pediatrics 1999;103 (4 Pt1):719-23.
  51. Sarginson RE, Taylor N, Reilly N, Baines PB, Van Saene HK. Infection in prolonged pediatric critical illness: A prospective four-year study based on knowledge of the carrier state. Crit Care Med 2004;32(3):839-47.
  52. Silvestri L, Monti Bragadin C, Milanese M, et al. Are most ICU infections really nosocomial? A prospective observational cohort study in mechanically ventilated patients. J Hosp Infect 1999;42(2):125-33.
  53. Heggers JP, Phillips LG, Boertman JA, et al. The epidemiology of methicillin-resistant Staphylococcus aureus in a burn center. J Burn Care Rehabil 1988;9(6):610-2.
  54. Donskey CJ. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis 2004;39(2):219-26.
  55. Osterholm MT, Hedberg CW, Moore KA. The epidemiology of infectious diseases. . In: G.L. M, Jr DRG, J.E. B, eds. Principles and Practice of Infectious Diseases. 5th ed ed. Philadelphia: Churchill Livingstone; 2000:161-3.
  56. Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Schonheyder HC, Sorensen HT. Risk of community-acquired pneumococcal bacteremia in patients with diabetes: a population-based case-control study. Diabetes Care 2004;27(5):1143-7.
  57. Carton JA, Maradona JA, Nuno FJ, Fernandez-Alvarez R, Perez-Gonzalez F, Asensi V. Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients. Eur J Med 1992;1(5):281-7.
  58. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 1995;333(13):845-51.
  59. Rosenberg AL, Seneff MG, Atiyeh L, Wagner R, Bojanowski L, Zimmerman JE. The importance of bacterial sepsis in intensive care unit patients with acquired immunodeficiency syndrome: implications for future care in the age of increasing antiretroviral resistance. Crit Care Med 2001;29(3):548-56.
  60. Malone JL, Ijaz K, Lambert L, et al. Investigation of healthcare-associated transmission of Mycobacterium tuberculosis among patients with malignancies at three hospitals and at a residential facility. Cancer 2004;101(12):2713-21.
  61. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998;338(24):1741-51.
  62. Safdar N, Kluger DM, Maki DG. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies. Medicine (Baltimore) 2002;81(6):466-79.
  63. Jarvis WR, Robles B. Nosocomial infections in pediatric patients. Adv Pediatr Infect Dis 1996;12:243-959(js).
  64. Yogaraj JS, Elward AM, Fraser VJ. Rate, risk factors, and outcomes of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics 2002;110(3):481-5.
  65. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis 2002;8(9):881-90.
  66. Rosen HR. Acquisition of hepatitis C by a conjunctival splash. Am J Infect Control 1997;25(3):242-7.
  67. Beltrami EM, Kozak A, Williams IT, et al. Transmission of HIV and hepatitis C virus from a nursing home patient to a health care worker. Am J Infect Control 2003;31(3):168-75.
  68. Obasanjo OO, Wu P, Conlon M, et al. An outbreak of scabies in a teaching hospital: lessons learned. Infect Control Hosp Epidemiol 2001;22(1):13-8.
  69. Andersen BM, Haugen H, Rasch M, Heldal Haugen A, Tageson A. Outbreak of scabies in Norwegian nursing homes and home care patients: control and prevention. J Hosp Infect 2000;45(2):160-4.
  70. Avitzur Y, Amir J. Herpetic whitlow infection in a general pediatrician-an occupational hazard. Infection 2002;30(4):234-6.
  71. Adams G, Stover BH, Keenlyside RA, et al. Nosocomial herpetic infections in a pediatric intensive care unit. Am J Epidemiol 1981;113(2):126-32.
  72. Bhalla A, Pultz NJ, Gries DM, et al. Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients. Infect Control Hosp Epidemiol 2004;25(2):164-7.
  73. Duckro AN, Blom DW, Lyle EA, Weinstein RA, Hayden MK. Transfer of vancomycin-resistant enterococci via health care worker hands. Arch Intern Med 2005;165(3):302-7.
  74. Brooks SE, Veal RO, Kramer M, Dore L, Schupf N, Adachi M. Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables. Infect Control Hosp Epidemiol 1992;13(2):98-103.
  75. CDC. Nosocomial hepatitis B virus infection associated with reusable fingerstick blood sampling devices--Ohio and New York City, 1996. MMWR Morb Mortal Wkly Rep 1997;46 (10):217-21.
  76. Desenclos JC, Bourdiol-Razes M, Rolin B, et al. Hepatitis C in a ward for cystic fibrosis and diabetic patients: possible transmission by spring-loaded finger-stick devices for self-monitoring of capillary blood glucose. Infect Control Hosp Epidemiol 2001;22(11):701-7.
  77. CDC. Transmission of hepatitis B virus among persons undergoing blood glucose monitoring in long-term-care facilities--Mississippi, North Carolina, and Los Angeles County, California, 2003-2004. MMWR Morb Mortal Wkly Rep 2005;54(9):220-3.
  78. Hall CB, Douglas RG, Jr. Modes of transmission of respiratory syncytial virus. J Pediatr 1981;99(1):100-3.
  79. Hall CB, Douglas RG, Jr., Geiman JM. Possible transmission by fomites of respiratory syncytial virus. J Infect Dis 1980;141(1):98-102.
  80. Buttery JP, Alabaster SJ, Heine RG, et al. Multiresistant Pseudomonas aeruginosa outbreak in a pediatric oncology ward related to bath toys. Pediatr Infect Dis J 1998;17(6):509-13.
  81. Agerton T, Valway S, Gore B, et al. Transmission of a highly drug-resistant strain (strain W1) of Mycobacterium tuberculosis. Community outbreak and nosocomial transmission via a contaminated bronchoscope. JAMA 1997;278(13):1073-7.
  82. Bronowicki JP, Venard V, Botte C, et al. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med 1997;337(4):237-40.
  83. Michele TM, Cronin WA, Graham NM, et al. Transmission of Mycobacterium tuberculosis by a fiberoptic bronchoscope. Identification by DNA fingerprinting. JAMA 1997;278(13):1093-5.
  84. Schelenz S, French G. An outbreak of multidrug-resistant Pseudomonas aeruginosa infection associated with contamination of bronchoscopes and an endoscope washer-disinfector. J Hosp Infect 2000;46(1):23-30.
  85. Weber DJ, Rutala WA. Lessons from outbreaks associated with bronchoscopy. Infect Control Hosp Epidemiol 2001;22(7):403-8.
  86. Kirschke DL, Jones TF, Craig AS, et al. Pseudomonas aeruginosa and Serratia marcescens contamination associated with a manufacturing defect in bronchoscopes. N Engl J Med 2003;348(3):214-20.
  87. Srinivasan A, Wolfenden LL, Song X, et al. An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes. N Engl J Med 2003;348(3):221-7.
  88. Boyce JM, Potter-Bynoe G, Chenevert C, King T. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 1997;18(9):622-7.(mj).
  89. Zachary KC, Bayne PS, Morrison VJ, Ford DS, Silver LC, Hooper DC. Contamination of gowns, gloves, and stethoscopes with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 2001;22(9):560-4.
  90. Perry C, Marshall R, Jones E. Bacterial contamination of uniforms. J Hosp Infect 2001;48(3):238-41.
  91. Papineni RS, Rosenthal FS. The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med 1997;10(2):105-16.
  92. Wells WF. On airborne infection: Study II. Droplets and droplet nuclei. . Am J Hygiene 1934;20:611-18.
  93. Loeb M, McGeer A, Henry B, et al. SARS among critical care nurses, Toronto. Emerg Infect Dis 2004;10(2):251-5.
  94. Fowler RA, Guest CB, Lapinsky SE, et al. Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation. Am J Respir Crit Care Med 2004;169(11):1198-202.
  95. Gehanno JF, Kohen-Couderc L, Lemeland JF, Leroy J. Nosocomial meningococcemia in a physician. Infect Control Hosp Epidemiol 1999;20(8):564-5.
  96. Scales D, et al. Illness in intensive-care staff after brief exposure to severe acute respiratory syndrome. Emerg Infect Dis 2003;9(10):1205-10.
  97. Ensor E, Humphreys H, Peckham D, Webster C, Knox AJ. Is Burkholderia (Pseudomonas) cepacia disseminated from cystic fibrosis patients during physiotherapy? J Hosp Infect 1996;32(1):9-15.
  98. Christian MD, Loutfy M, McDonald LC, et al. Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerg Infect Dis 2004;10(2):287-93.
  99. Valenzuela TD, Hooton TM, Kaplan EL, Schlievert P. Transmission of 'toxic strep' syndrome from an infected child to a firefighter during CPR. Ann Emerg Med 1991;20(1):90-2.
  100. Bassinet L, Matrat M, Njamkepo E, Aberrane S, Housset B, Guiso N. Nosocomial pertussis outbreak among adult patients and healthcare workers. Infect Control Hosp Epidemiol 2004;25(11):995-7.
  101. Wong TW, Lee CK, Tam W, et al. Cluster of SARS among medical students exposed to single patient, Hong Kong. Emerg Infect Dis 2004;10(2):269-76.
  102. Pachucki CT, Pappas SA, Fuller GF, Krause SL, Lentino JR, Schaaff DM. Influenza A among hospital personnel and patients. Implications for recognition, prevention, and control. Arch Intern Med 1989;149(1):77-80.
  103. Feigin RD, Baker CJ, Herwaldt LA, Lampe RM, Mason EO, Whitney SE. Epidemic meningococcal disease in an elementary-school classroom. N Engl J Med 1982;307(20):1255-7.
  104. Dick EC, Jennings LC, Mink KA, Wartgow CD, Inhorn SL. Aerosol transmission of rhinovirus colds. J Infect Dis 1987;156(3):442-8.
  105. Duguid JP. The size and duration of air-carriage of respiratory droplets and droplet nucleii. J Hyg (Lond) 1946;44:471-9.
  106. Hall CB, Douglas RG, Jr., Schnabel KC, Geiman JM. Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun 1981;33(3):779-83.
  107. Downie AW, Meiklejohn M, St Vincent L, Rao AR, Sundara Babu BV, Kempe CH. The recovery of smallpox virus from patients and their environment in a smallpox hospital. Bull World Health Organ 1965;33(5):615-22.
  108. Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. The epidemiology of smallpox. In: Smallpox and its eradication. Switzerland: World Health Orginization; 1988.
  109. Cole EC, Cook CE. Characterization of infectious aerosols in health care facilities: an aid to effective engineering controls and preventive strategies. Am J Infect Control 1998;26(4):453-64.
  110. Christie C, Mazon D, Hierholzer W, Jr., Patterson JE. Molecular heterogeneity of Acinetobacter baumanii isolates during seasonal increase in prevalence. Infect Control Hosp Epidemiol 1995;16(10):590-4.
  111. Musher DM. How contagious are common respiratory tract infections? N Engl J Med 2003;348(13):1256-66.
  112. Steinberg P, White RJ, Fuld SL, Gutekunst RR, Chanock RM, Senterfit LB. Ecology of Mycoplasma pneumoniae infections in marine recruits at Parris Island, South Carolina. Am J Epidemiol 1969;89(1):62-73.
  113. Seto WH, Tsang D, Yung RW, et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003;361(9368):1519-20.
  114. Hamburger M, Robertson OH. Expulsion of group A haemolytic streptocicci in droplets and droplet nuclei by sneezing, coughing and talking. Am J Med 1948;4:690.
  115. CDC. Nosocomial meningococcemia. MMWR Morb Mortal Wkly Rep 1978;27:358.
  116. LeClair JM, Freeman J, Sullivan BF, Crowley CM, Goldmann DA. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N Engl J Med 1987;317(6):329-34.
  117. Madge P, Paton JY, McColl JH, Mackie PL. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus. Lancet 1992;340(8827):1079-83.
  118. Bassetti S, Bischoff WE, Walter M, et al. Dispersal of Staphylococcus aureus Into the Air Associated With a Rhinovirus Infection. Infect Control Hosp Epidemiol 2005;26(2):196-203.
  119. Eichenwald HF, Kotsevalov O, Fasso LA. The "cloud baby": an example of bacterial-viral interaction. Am J Dis Child 1960;100:161-73.
  120. Sheretz RJ, Reagan DR, Hampton KD, et al. A cloud adult: the Staphylococcus aureus-virus interaction revisited. Ann Intern Med 1996;124(6):539-47.
  121. Coronado VG, Beck-Sague CM, Hutton MD, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis 1993;168(4):1052-5.
  122. Bloch AB, Orenstein WA, Ewing WM, et al. Measles outbreak in a pediatric practice: airborne transmission in an office setting. Pediatrics 1985;75(4):676-83.
  123. LeClair JM, Zaia JA, Levin MJ, Congdon RG, Goldmann DA. Airborne transmission of chickenpox in a hospital. N Engl J Med 1980;302(8):4503.
  124. Riley RL, Mills CC, Nyka W, et al. Aerial dissemination of pulmonary tuberculosis. A two-year study of contagion in a tuberculosis ward. 1959. Am J Hyg 1959;70:185-96.
  125. Beck-Sague C, Dooley SW, Hutton MD, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. JAMA 1992;268(10):1280-6.
  126. CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. Centers for Disease Control and Prevention. MMWR Recomm Rep 1994;43(RR-13):1-132.
  127. Haley CE, McDonald RC, Rossi L, Jones WD, Jr., Haley RW, Luby JP. Tuberculosis epidemic among hospital personnel. Infect Control Hosp Epidemiol 1989;10(5):204-10.
  128. Wehrle PF, Posch J, Richter KH, Henderson DA. An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe. Bull World Health Organ 1970;43(5):669-79.
  129. Gelfand HM, Posch J. The recent outbreak of smallpox in Meschede, West Germany. Am J Epidemiol 1971;93(4):234-7.
  130. Moser MR, Bender TR, Margolis HS, Noble GR, Kendal AP, Ritter DG. An outbreak of influenza aboard a commercial airliner. Am J Epidemiol 1979;110(1):1-6.
  131. Alford RH, Kasel JA, Gerone PJ, Knight V. Human influenza resulting from aerosol inhalation. Proc Soc Exp Biol Med 1966;122(3):800-4.
  132. Chadwick PR, McCann R. Transmission of a small round structured virus by vomiting during a hospital outbreak of gastroenteritis. J Hosp Infect 1994;26(4):251-9.
  133. Prince DS, Astry C, Vonderfecht S, Jakab G, Shen FM, Yolken RH. Aerosol transmission of experimental rotavirus infection. Pediatr Infect Dis 1986;5(2):218-22.
  134. www.cdc.gov/ncidod/sars.
  135. Peiris JS, Yuen KY, Osterhaus AD, Stohr K. The severe acute respiratory syndrome. N Engl J Med 2003;349(25):2431-41.
  136. Olsen SJ, Chang HL, Cheung TY, et al. Transmission of the severe acute respiratory syndrome on aircraft. N Engl J Med 2003;349(25):2416-22.
  137. Wilder-Smith A, Leong HN, Villacian JS. In-flight transmission of Severe Acute Respiratory Syndrome (SARS): A Case Report. J Travel Med 2003;10(5):299-300.
  138. Booth TF, Kournikakis B, Bastien N, et al. Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units. J Infect Dis 2005;191(9):1472-7.
  139. Yu IT, Li Y, Wong TW, et al. Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med 2004;350(17):1731-9.
  140. CDC. Update: Outbreak of severe acute respiratory syndrome--worldwide. MMWR Morb Mortal Wkly Rep 2003;52 (12):241-6, 8.
  141. CDC. Cluster of severe acute respiratory syndrome cases among protected health-care workers--Toronto, Canada, April 2003. MMWR Morb Mortal Wkly Rep 2003;52(19):433-6.
  142. Sawyer LA, Murphy JJ, Kaplan JE, et al. 25- to 30-nm virus particle associated with a hospital outbreak of acute gastroenteritis with evidence for airborne transmission. Am J Epidemiol 1988;127(6):1261-71.
  143. Marks PJ, Vipond IB, Carlisle D, Deakin D, Fey RE, Caul EO. Evidence for airborne transmission of Norwalk-like virus (NLV) in a hotel restaurant. Epidemiol Infect 2000;124(3):481-7.
  144. Salgado CD, Farr BM, Hall KK, Hayden FG. Influenza in the acute hospital setting. Lancet Infect Dis 2002;2(3):145-55.
  145. Riley RL. Airborne infection. Am J Med 1974;57(3):466-75.
  146. McLean R. General discussion. . Am Rev Respir Dis 1961;83 36–8.
  147. Cheesbrough JS, Green J, Gallimore CI, Wright PA, Brown DW. Widespread environmental contamination with Norwalk-like viruses (NLV) detected in a prolonged hotel outbreak of gastroenteritis. Epidemiol Infect 2000;125(1):93-8.
  148. Marks PJ, Vipond IB, Regan FM, Wedgwood K, Fey RE, Caul EO. A school outbreak of Norwalk-like virus: evidence for airborne transmission. Epidemiol Infect 2003;131(1):727-36.
  149. Roy CJ, Milton DK. Airborne transmission of communicable infection-the elusive pathway. N Engl J Med 2004;350(17):1710-2.
  150. Dull PM, Wilson KE, Kournikakis B, et al. Bacillus anthracis aerosolization associated with a contaminated mail sorting machine. Emerg Infect Dis 2002;8(10):1044-7.
  151. Weis CP, Intrepido AJ, Miller AK, et al. Secondary aerosolization of viable Bacillus anthracis spores in a contaminated US Senate Office. JAMA 2002;288(22):2853-8.
  152. Patterson JE, Zidouh A, Miniter P, Andriole VT, Patterson TF. Hospital epidemiologic surveillance for invasive aspergillosis: patient demographics and the utility of antigen detection. Infect Control Hosp Epidemiol 1997;18(2):104-8.
  153. Arnow PM, Andersen RL, Mainous PD, Smith EJ. Pumonary aspergillosis during hospital renovation. Am Rev Respir Dis 1978;118(1):49-53.
  154. Pegues DA, Lasker BA, McNeil MM, Hamm PM, Lundal JL, Kubak BM. Cluster of cases of invasive aspergillosis in a transplant intensive care unit: evidence of person-to-person airborne transmission. Clin Infect Dis 2002;34(3):412-6.
  155. Buffington J, Reporter R, Lasker BA, et al. Investigation of an epidemic of invasive aspergillosis: utility of molecular typing with the use of random amplified polymorphic DNA probes. Pediatr Infect Dis J 1994;13(5):38693.
  156. Krasinski K, Holzman RS, Hanna B, Greco MA, Graff M, Bhogal M. Nosocomial fungal infection during hospital renovation. Infect Control 1985;6(7):278-82.
  157. Humphreys H. Positive-pressure isolation and the prevention of invasive aspergillosis. What is the evidence? J Hosp Infect 2004;56(2):93-100.
  158. Thio CL, Smith D, Merz WG, et al. Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit. Infect Control Hosp Epidemiol 2000;21(1):18-23.
  159. Anaissie EJ, Stratton SL, Dignani MC, et al. Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. Clin Infect Dis 2002;34(6):780-9.
  160. CDC. Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis 2002;35 (8):950-9.
  161. Gruteke P, van Belkum A, Schouls LM, et al. Outbreak of group A streptococci in a burn center: use of pheno- and genotypic procedures for strain tracking. J Clin Microbiol 1996;34(1):114-8.
  162. Greene CM, Van Beneden CA, Javadi M, et al. Cluster of deaths from group A streptococcus in a long-term care facility--Georgia, 2001. Am J Infect Control 2005;33(2):108-13.
  163. Sabria M, Campins M. Legionnaires' disease: update on epidemiology and management options. Am J Respir Med 2003;2(3):235-43.
  164. Bille J, Marchetti O, Calandra T. Changing face of health-care associated fungal infections. Curr Opin Infect Dis 2005;18(4):314-9.
  165. Hall IC, O'Toole E. Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child 1935;49:390-402.
  166. George WL, Sutter VL, Finegold SM. Antimicrobial agent-induced diarrhea--a bacterial disease. J Infect Dis 1977;136(6):822-8.
  167. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320(4):204-10.
  168. Pepin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Cmaj 2004;171(5):466-72.
  169. Agency HP. Outbreak of Clostridium difficile infection in a hospital in south east England. Communicable Disease Report Weekly 2005;31(24).
  170. Koopmans M, Wilbrink B, Conyn M, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004;363(9409):587-93.
  171. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353(23):243341.
  172. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353(23):2442-9.
  173. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005;366(9491):1079-84.
  174. Layton BA ML, Gerding DN, Liedtke LA, Strausbaugh LJ. Perceived increases in the incidence and severity of Clostridium difficile disease: an emerging threat that continues to unfold. In: 15th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America;. Los Angeles, CA.; 2005.
  175. Sohn S, Climo M, Diekema D, et al. Varying rates of Clostridium difficile-associated diarrhea at prevention epicenter hospitals. Infect Control Hosp Epidemiol 2005;26(8):676-9.
  176. IOM. Antimicrobial Resistance: Issues and Options. Workshop report. In: Harrison PF, Lederberg J, eds. Washington, DC: National Academy Press; 1998:8-74.
  177. Shlaes DM, Gerding DN, John JF, Jr., et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997;18(4):275-91.
  178. Whitener CJ, Park SY, Browne FA, et al. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin Infect Dis 2004;38(8):1049-55.
  179. CDC. Staphylococcus aureus with reduced susceptibility to vancomycin-United States. MMWR Morb Mortal Wkly Rep 1997;46 (33):765-6.
  180. CDC. Staphylococcus aureus resistant to vancomycin--United States, 2002. MMWR Morb Mortal Wkly Rep 2002;51 (26):565-7.
  181. CDC. Public Health Dispatch: Vancomycin-Resistant Staphylococcus aureus --- Pennsylvania, 2002. MMWR - Morbidity & Mortality Weekly Report 2002;51(40):902.
  182. CDC. Vancomycin-resistant Staphylococcus aureus--New York, 2004. MMWR Morb Mortal Wkly Rep 2004;53(15):322-3.
  183. Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003;348(14):1342-7.
  184. Fridkin SK, Hageman J, McDougal LK, et al. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 19972001. Clin Infect Dis 2003;36(4):429-39.
  185. Gold HS, Moellering RC, Jr. Antimicrobial-drug resistance. N Engl J Med 1996;335(19):1445-53.
  186. Hageman JC, Pegues DA, Jepson C, et al. Vancomycin-intermediate Staphylococcus aureus in a home health-care patient. Emerg Infect Dis 2001;7(6):1023-5.
  187. Harwell JI, Brown RB. The drug-resistant pneumococcus: clinical relevance, therapy, and prevention. Chest 2000;117(2):530-41.
  188. Jones RN. Resistance patterns among nosocomial pathogens: trends over the past few years. Chest 2001;119(2 Suppl):397S-404S.
  189. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000;342(10):710-21.
  190. Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003;289(7):885-8.
  191. Pitout JD, Sanders CC, Sanders WE, Jr. Antimicrobial resistance with focus on beta-lactam resistance in gram- negative bacilli. Am J Med 1997;103(1):51-9.
  192. Rotun SS, McMath V, Schoonmaker DJ, et al. Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. Emerg Infect Dis 1999;5(1):147-9.
  193. Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 1999;340(7):493501.
  194. Srinivasan A, Dick JD, Perl TM. Vancomycin resistance in staphylococci. Clin Microbiol Rev 2002;15(3):430-8.
  195. Hyle EP, Lipworth AD, Zaoutis TE, et al. Risk Factors for Increasing Multidrug Resistance among Extended-Spectrum ß-lactamase-Lactamase-Producing Escheria coli and Klebsiella species Clin Infect Dis 2005;40(9):1317-24.
  196. Gleich S, Morad Y, Echague R, et al. Streptococcus pneumoniae serotype 4 outbreak in a home for the aged: report and review of recent outbreaks. Infect Control Hosp Epidemiol 2000;21:711.
  197. Fry AM, Udeagu CC, Soriano-Gabarro M, et al. Persistence of fluoroquinolone-resistant, multidrug-resistant Streptococcus pneumoniae in a long-term-care facility: efforts to reduce intrafacility transmission. Infect Control Hosp Epidemiol 2005;26(3):239-47.
  198. Carter RJ, Sorenson G, Heffernan R, et al. Failure to control an outbreak of multidrug-resistant Streptococcus pneumoniae in a long-term-care facility: emergence and ongoing transmission of a fluoroquinoloneresistant strain. Infect Control Hosp Epidemiol 2005;26(3):248-55.
  199. Blok HE, Troelstra A, Kamp-Hopmans TE, et al. Role of healthcare workers in outbreaks of methicillin-resistant Staphylococcus aureus: a 10year evaluation from a Dutch university hospital. Infect Control Hosp Epidemiol 2003;24(9):679-85.
  200. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003;24(5):362-86.
  201. Tammelin A, Klotz F, Hambraeus A, Stahle E, Ransjo U. Nasal and hand carriage of Staphylococcus aureus in staff at a Department for Thoracic and Cardiovascular Surgery: endogenous or exogenous source? Infect Control Hosp Epidemiol 2003;24(9):686-9.
  202. CDC. Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR Recomm Rep 2000;49(RR-4):1-14.
  203. Inglesby TV, O'Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002;287(17):2236-52.
  204. Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 1999;281(22):2127-37.
  205. www.bt.cdc.gov/agent/smallpox/
  206. www.who.int/csr/disease/smallpox/en/
  207. Kool JL. Risk of person-to-person transmission of pneumonic plague. Clin Infect Dis 2005;40(8):1166-72.
  208. Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 2000;283(17):2281-90.
  209. Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001;285(8):1059-70.
  210. Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001;285(21):2763-73.
  211. CDC. Notice to Readers Update: Management of Patients with Suspected Viral Hemorrhagic Fever -- United States. MMWR Recomm Rep 1995;44(25):475-9.
  212. Borio L, Inglesby T, Peters CJ, et al. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 2002;287(18):2391-405.
  213. Neff JM, Lane JM, Fulginiti VA, Henderson DA. Contact vaccinia-transmission of vaccinia from smallpox vaccination. JAMA 2002;288(15):1901-5.
  214. Sepkowitz KA. How contagious is vaccinia? N Engl J Med 2003;348(5):439-46.
  215. Lane JM, Fulginiti VA. Transmission of vaccinia virus and rationale for measures for prevention. Clin Infect Dis 2003;37(2):281-4.
  216. CDC. Smallpox Vaccination and Adverse Reactions: Guidance for Clinicians. MMWR - Morbidity & Mortality Weekly Report 2003;52(RR04):1-28.
  217. Fulginiti VA, Papier A, Lane JM, Neff JM, Henderson DA. Smallpox vaccination: a review, part II. Adverse events. Clin Infect Dis 2003;37(2):251-71.
  218. www.smallpox.mil./event/SPSafetySum.asp
  219. CDC. Update: adverse events following civilian smallpox vaccination-United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52(18):41920.
  220. CDC. Secondary and tertiary transfer of vaccinia virus among U.U. military personnel--United States and worldwide, 2002-2004. MMWR Morb Mortal Wkly Rep 2004;53(5):103-5.
  221. Talbot TR, Ziel E, Doersam JK, LaFleur B, Tollefson S, Edwards KM. Risk of vaccinia transfer to the hands of vaccinated persons after smallpox immunization. Clin Infect Dis 2004;38(4):536-41.
  222. Hepburn MJ, Dooley DP, Murray CK, et al. Frequency of vaccinia virus isolation on semipermeable versus nonocclusive dressings covering smallpox vaccination sites in hospital personnel. Am J Infect Control 2004;32(3):126-30.
  223. Waibel KH, Ager EP, Topolski RL, Walsh DS. Randomized trial comparing vaccinia on the external surfaces of 3 conventional bandages applied to smallpox vaccination sites in primary vaccinees. Clin Infect Dis 2004;39(7):1004-7.
  224. Tenorio AR, Peeples M, Patri M, et al. Quantitative Vaccinia Cultures and Evolution of Vaccinia-Specific CD8+ Cytotoxic T-lymphocytes (CTL) Responses in Revaccinees. Abstract #823, 41st Annual Meeting IDSA, October 2003, San Diego 2003.
  225. Wharton M, Strikas RA, Harpaz R, et al. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003;52(RR-7):1-16.
  226. CDC. Surveillance for Creutzfeldt-Jakob Disease -- United States. MMWR 1996;45(31):665-8.
  227. Johnson RT, Gibbs CJ, Jr. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 1998;339(27):1994-2004.
  228. Brown P, Gajdusek DC, Gibbs CJ, Jr., Asher DM. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med 1985;313(12):728-31.
  229. Frasier SD, Foley TP, Jr. Clinical review 58: Creutzfeldt-Jakob disease in recipients of pituitary hormones. J Clin Endocrinol Metab 1994;78(6):1277-9.
  230. CDC. Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts--Japan, 1979-2003. MMWR Morb Mortal Wkly Rep 2003;52(48):1179-81.
  231. Lang CJ, Heckmann JG, Neundorfer B. Creutzfeldt-Jakob disease via dural and corneal transplants. J Neurol Sci 1998;160(2):128-39.
  232. el Hachimi KH, Chaunu MP, Cervenakova L, Brown P, Foncin JF. Putative neurosurgical transmission of Creutzfeldt-Jakob disease with analysis of donor and recipient: agent strains. C R Acad Sci III 1997;320(4):319-28.
  233. Will RG, Matthews WB. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1982;45(3):2358.
  234. Bernoulli C, Siegfried J, Baumgartner G, et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977;1(8009):478-9.
  235. Rutala WA, Weber DJ. Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization. Clin Infect Dis 2001;32(9):1348-56.
  236. Belay ED, Maddox RA, Williams ES, Miller MW, Gambetti P, Schonberger LB. Chronic wasting disease and potential transmission to humans. Emerg Infect Dis 2004;10(6):977-84.
  237. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996;383(6602):685-90.
  238. Belay ED, Schonberger LB. The public health impact of prion diseases. Annu Rev Public Health 2005;26:191-212.
  239. Belay ED, Schonberger LB. Variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Clin Lab Med 2002;22(4):849-62, v-vi.
  240. Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999;353(9148):183-9.
  241. Evatt B. Creutzfeldt-Jakob disease and haemophilia: assessment of risk. Haemophilia 2000;6 Suppl 1:94-9.
  242. Chamberland ME. Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products? Clin Infect Dis 2002;34(6):797-805.
  243. www.fda.gov/cber/gdlns/cjdvcjd.htm
  244. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363(9407):417-21.
  245. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364(9433):527-9.
  246. Brown P. Guidelines for high risk autopsy cases: special precautions for Creutzfeldt-Jakob Disease. In: Hutchins G, ed. Autopsy Performance and Reporting, Northfield, Ill.:. College of American Pathologists 1990:68-74.
  247. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348(20):1967-76.
  248. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348(20):1953-66.
  249. Chan WM, Kwan YW, Wan HS, Leung CW, Chiu MC. Epidemiologic linkage and public health implication of a cluster of severe acute respiratory syndrome in an extended family. Pediatr Infect Dis J 2004;23(12):1156-9.
  250. Leung CW, Kwan YW, Ko PW, et al. Severe acute respiratory syndrome among children. Pediatrics 2004;113(6):e535-43.
  251. Bitnun A, Allen U, Heurter H, et al. Children hospitalized with severe acute respiratory syndrome-related illness in Toronto. Pediatrics 2003;112(4):e261.
  252. Chow KY, Lee CE, Ling ML, Heng DM, Yap SG. Outbreak of severe acute respiratory syndrome in a tertiary hospital in Singapore, linked to an index patient with atypical presentation: epidemiological study. Bmj 2004;328(7433):195.
  253. Shen Z, Ning F, Zhou W, et al. Superspreading SARS events, Beijing, 2003. Emerg Infect Dis 2004;10(2):256-60.
  254. Chen Y-C, Huang L-M, Chan C-C, et al. SARS in Hospital Emergency Room. Emerg Infect Dis 2004;10:782-8.
  255. Chung Y-C, Huang L-M, Chan C-C, et al. SARS in Hospital Emergency Room. Emerg Infect Dis 2004;10:782-8.
  256. Gamage B, Moore D, Copes R, Yassi A, Bryce E. Protecting health care workers from SARS and other respiratory pathogens: a review of the infection control literature. Am J Infect Control 2005;33(2):114-21.
  257. Moore D, Gamage B, Bryce E, Copes R, Yassi A. Protecting health care workers from SARS and other respiratory pathogens: organizational and individual factors that affect adherence to infection control guidelines. Am J Infect Control 2005;33(2):88-96.
  258. Dowell SF, Simmerman JM, Erdman DD, et al. Severe acute respiratory syndrome coronavirus on hospital surfaces. Clin Infect Dis 2004;39(5):652-7.
  259. Public Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory Syndrome (SARS). 2004. (Accessed at http://www.cdc.gov/ncidod/sars/guidance/I/occupational.htm.)
  260. Le DH, Bloom SA, Nguyen QH, et al. Lack of SARS transmission among public hospital workers, Vietnam. Emerg Infect Dis 2004;10(2):265-8.
  261. Lim PL, Kurup A, Gopalakrishna G, et al. Laboratory-acquired severe acute respiratory syndrome. N Engl J Med 2004;350(17):1740-5.
  262. CDC. www.cdc.gov/ncidod/sars. 2003.
  263. Reed KD, Melski JW, Graham MB, et al. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med 2004;350(4):342-50.
  264. Anderson MG, Frenkel LD, Homann S, Guffey J. A case of severe monkeypox virus disease in an American child: emerging infections and changing professional values. Pediatr Infect Dis J 2003;22:1093-6.
  265. Jezek Z, Fenner F. Human monkey pox. In: Melnick JL ed. Monographs in virology. Vol. 17. Basel, Switzerland: S Karger AG. 1988:81-102.
  266. Marennikova SS, Jezek Z, Szczeniowski M, Mbudi PM, Vernette M. [Contagiousness of monkey pox for humans: results of an investigation of 2 outbreaks of the infection in Zaire]. Zh Mikrobiol Epidemiol Immunobiol 1985(8):38-43.
  267. Jezek Z, Arita I, Mutombo M, Dunn C, Nakano JH, Szczeniowski M. Four generations of probable person-to-person transmission of human monkeypox. Am J Epidemiol 1986;123(6):1004-12.
  268. Learned LA, Reynolds MG, Wassa DW, et al. Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am J Trop Med Hyg 2005;73(2):428-34.
  269. Fleischauer AT, Kile JC, Davidson M, et al. Evaluation of human-tohuman transmission of monkeypox from infected patients to health care workers. Clin Infect Dis 2005;40(5):689-94.
  270. Likos AM, Sammons SA, Olson VA, et al. A tale of two clades: monkeypox viruses. J Gen Virol 2005;86(Pt 10):2661-72.
  271. Fine PE, Jezek Z, Grab B, Dixon H. The transmission potential of monkeypox virus in human populations. Int J Epidemiol 1988;17(3):64350.
  272. Jezek Z, Grab B, Paluku KM, Szczeniowski MV. Human monkeypox: disease pattern, incidence and attack rates in a rural area of northern Zaire. Trop Geogr Med 1988;40(2):73-83.
  273. CDC. "Norwalk-Like Viruses":Public Health Consequences and Outbreak Management. MMWR - Morbidity & Mortality Weekly Report 2001;50 (RR-09)(June):1-18.
  274. Evans MR, Meldrum R, Lane W, et al. An outbreak of viral gastroenteritis following environmental contamination at a concert hall. Epidemiol Infect 2002;129(2):355-60.
  275. Wu HM, Fornek M, Kellogg JS, et al. A Norovirus Outbreak at a Long-Term-Care Facility: The Role of Environmental Surface Contamination. Infect Control Hosp Epidemiol 2005;26(10):802-10.
  276. Duizer E, Schwab KJ, Neill FH, Atmar RL, Koopmans MP, Estes MK. Laboratory efforts to cultivate noroviruses. J Gen Virol 2004;85(Pt 1):7987.
  277. Zingg W, Colombo C, Jucker T, Bossart W, Ruef C. Impact of an outbreak of norovirus infection on hospital resources. Infect Control Hosp Epidemiol 2005;26:263-7.
  278. Calderon-Margalit R, Sheffer R, Halperin T, Orr N, Cohen D, Shohat T. A large-scale gastroenteritis outbreak associated with Norovirus in nursing homes. Epidemiol Infect 2005;133(1):35-40. 279.
  279. Marx A, Shay DK, Noel JS, et al. An outbreak of acute gastroenteritis in a geriatric long-term-care facility: combined application of epidemiological and molecular diagnostic methods. Infect Control Hosp Epidemiol 1999;20(5):306-11.
  280. Gellert GA, Waterman SH, Ewert D, et al. An outbreak of acute gastroenteritis caused by a small round structured virus in a geriatric convalescent facility. Infect Control Hosp Epidemiol 1990;11(9):459-64.
  281. Cooper E, Blamey S. A Norovirus Gastroenteritis Epidemic in a Long-Term-Care Facility. Infect Control Hosp Epidemiol 2005;26(3):256.
  282. Navarro G, Sala RM, Segura F, et al. An Outbreak of Norovirus Infection in a Long-Term-Care. Infect Control Hosp Epidemiol 2005;26(3):259.
  283. Green KY, Belliot G, Taylor JL, et al. A predominant role for Norwalk-like viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly. J Infect Dis 2002;185(2):133-46. 284.
  284. Widdowson MA, Cramer EH, Hadley L, et al. Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus--United States, 2002. J Infect Dis 2004;190(1):27-36.
  285. CDC. Outbreaks of gastroenteritis associated with noroviruses on cruise ships--United States, 2002. MMWR Morb Mortal Wkly Rep 2002;51(49):1112-5.
  286. CDC. Norovirus outbreak among evacuees from hurricane Katrina-Houston, Texas, September 2005. MMWR Morb Mortal Wkly Rep 2005;54(40):1016-8.
  287. Mattner F, Mattner L, Borck HU, Gastmeier P. Evaluation of the Impact of the Source (Patient Versus Staff) on Nosocomial Norovirus Outbreak Severity. Infect Control Hosp Epidemiol 2005;26(3):268-72.
  288. Isakbaeva ET, Bulens SN, Beard RS, et al. Norovirus and child care: challenges in outbreak control. Pediatr Infect Dis J 2005;24(6):561-3.
  289. Kapikian AZ, Estes MK, Chanock RM. Norwalk group of viruses. In: Fields BN, Knipe DM, Howley PM, eds. Fields virology. 3rd ed. Philadelphia, PA: Lippincott-Raven. 1996:783-810.
  290. Duizer E, Bijkerk P, Rockx B, De Groot A, Twisk F, Koopmans M. Inactivation of caliciviruses. Appl Environ Microbiol 2004;70(8):4538-43.
  291. Doultree JC, Druce JD, Birch CJ, Bowden DS, Marshall JA. Inactivation of feline calicivirus, a Norwalk virus surrogate. J Hosp Infect 1999;41(1):51-7.
  292. Barker J, Vipond IB, Bloomfield SF. Effects of cleaning and disinfection in reducing the spread of Norovirus contamination via environmental surfaces. J Hosp Infect 2004;58(1):42-9.
  293. Gulati BR, Allwood PB, Hedberg CW, Goyal SM. Efficacy of commonly used disinfectants for the inactivation of calicivirus on strawberry, lettuce, and a food-contact surface. J Food Prot 2001;64(9):1430-4.
  294. Gehrke C, Steinmann J, Goroncy-Bermes P. Inactivation of feline calicivirus, a surrogate of norovirus (formerly Norwalk-like viruses), by different types of alcohol in vitro and in vivo. J Hosp Infect 2004;56(1):49-55.
  295. Hutson AM, Atmar RL, Graham DY, Estes MK. Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis 2002;185(9):1335-7.
  296. National Center for Infectious Diseases - Division of Viral and Rickettsial Diseases. (www.cdc.gov/ncidod/dvrd/index.htm
  297. LeDuc JW. Epidemiology of hemorrhagic fever viruses. Rev Infect Dis 1989;11 Suppl 4:S730-5.
  298. Roels TH, Bloom AS, Buffington J, et al. Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis 1999 Feb;179 Suppl 1:S92-7.
  299. Suleiman MN, Muscat-Baron JM, Harries JR, et al. Congo/Crimean haemorrhagic fever in Dubai. An outbreak at the Rashid Hospital. Lancet 1980;2(8201):939-41.
  300. Monath TP, Mertens PE, Patton R, et al. A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg 1973;22(6):773-9.
  301. Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999 Feb;179 Suppl 1:S87-91.
  302. Peters CJ. Marburg and Ebola--arming ourselves against the deadly filoviruses. N Engl J Med 2005;352(25):2571-3.
  303. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 1978;56(2):271-93.
  304. Emond RT, Evans B, Bowen ET, Lloyd G. A case of Ebola virus infection. Br Med J 1977;2(6086):541-4.
  305. Zaki SR, Shieh WJ, Greer PW, et al. A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 1999;179 Suppl 1:S36-47.
  306. Khan AS, Tshioko FK, Heymann DL, et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 1999;179 Suppl 1:S76-86.
  307. Muyembe-Tamfum JJ, Kipasa M, Kiyungu C, Colebunders R. Ebola outbreak in Kikwit, Democratic Republic of the Congo: discovery and control measures. J Infect Dis 1999;179 Suppl 1:S259-62.
  308. Haas WH, Breuer T, Pfaff G, et al. Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis 2003;36(10):1254-8.
  309. Simpson DI. Marburg agent disease: in monkeys. Trans R Soc Trop Med Hyg 1969;63(3):303-9.
  310. Jaax NK, Davis KJ, Geisbert TJ, et al. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med 1996;120(2):140-55.
  311. Stephenson EH, Larson EW, Dominik JW. Effect of environmental factors on aerosol-induced Lassa virus infection. J Med Virol 1984;14(4):295303.
  312. Johnson E, Jaax N, White J, Jahrling P. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol 1995;76(4):227-36.
  313. Jaax N, Jahrling P, Geisbert T, et al. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 1995;346(8991-8992):1669-71.
  314. www.bt.cdc.gov/agent/vhf/.
  315. Nguyen GT, Proctor SE, Sinkowitz-Cochran RL, Garrett DO, Jarvis WR. Status of infection surveillance and control programs in the United States, 1992-1996. Association for Professionals in Infection Control and Epidemiology, Inc. Am J Infect Control 2000;28(6):392-400.
  316. Richards C, Emori TG, Edwards J, Fridkin S, Tolson J, Gaynes R. Characteristics of hospitals and infection control professionals participating in the National Nosocomial Infections Surveillance System 1999. Am J Infect Control 2001;29(6):400-3.
  317. Wenzel RP, Thompson RL, Landry SM, et al. Hospital-acquired infections in intensive care unit patients: an overview with emphasis on epidemics. Infect Control 1983;4(5):371-5.
  318. Wenzel RP, Gennings C. Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies. Clin Infect Dis 2005;41 Suppl 6:S389-93.
  319. San Miguel LG, Cobo J, Otheo E, Sanchez-Sousa A, Abraira V, Moreno S. Secular trends of candidemia in a large tertiary-care hospital from 1988 to 2000: emergence of Candida parapsilosis. Infect Control Hosp Epidemiol 2005;26(6):548-52.
  320. NNIS. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32(8):470-85.
  321. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999;27(5):887-92.
  322. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000;21(8):510-5.
  323. Hugonnet S, Eggimann P, Borst F, Maricot P, Chevrolet JC, Pittet D. Impact of ventilator-associated pneumonia on resource utilization and patient outcome. Infect Control Hosp Epidemiol 2004;25(12):1090-6.
  324. O'Neill JM, Schutze GE, Heulitt MJ, Simpson PM, Taylor BJ. Nosocomial infections during extracorporeal membrane oxygenation. Intensive Care Med 2001;27(8):1247-53.
  325. Villegas MV, Hartstein AI. Acinetobacter Outbreaks, 1977–2000. Infect Control Hosp Epidemiol 2003;24(4):284-95.
  326. Gordon SM, Schmitt SK, Jacobs M, et al. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg 2001;72(3):725-30.
  327. Giamarellou H. Nosocomial cardiac infections. J Hosp Infect 2002;50(2):91-105.
  328. Fridkin SK. Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med 2001;29(4 Suppl):N64-8.
  329. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001;134(4):298-314.
  330. Fridkin SK, Edwards JR, Courval JM, et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 2001;135(3):175-83.
  331. Crnich CJ, Safdar N, Maki DG. The role of the intensive care unit environment in the pathogenesis and prevention of ventilator-associated pneumonia. Respir Care 2005;50(6):813-36; discussion 36-8.
  332. Knaus WA, Wagner DP, Zimmerman JE, Draper EA. Variations in mortality and length of stay in intensive care units. Ann Intern Med 1993;118(10):753-61.
  333. Villarino ME, Stevens LE, Schable B, et al. Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients. Infect Control Hosp Epidemiol 1992;13(4):201-6.
  334. Sanchez V, Vazquez JA, Barth-Jones D, Dembry L, Sobel JD, Zervos MJ. Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. Am J Med 1993;94(6):577-82.
  335. Husni RN, Goldstein LS, Arroliga AC, et al. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 1999;115(5):1378-82.
  336. McDonald LC, Walker M, Carson L, et al. Outbreak of Acinetobacter spp. bloodstream infections in a nursery associated with contaminated aerosols and air conditioners. Pediatr Infect Dis J 1998;17(8):716-22.
  337. Trick WE, Kioski CM, Howard KM, et al. Outbreak of Pseudomonas aeruginosa ventriculitis among patients in a neurosurgical intensive care unit. Infect Control Hosp Epidemiol 2000;21(3):204-8.
  338. Guidry GG, Black-Payne CA, Payne DK, Jamison RM, George RB, Bocchini JA, Jr. Respiratory syncytial virus infection among intubated adults in a university medical intensive care unit. Chest 1991;100(5):137784.
  339. Wurtz R, Karajovic M, Dacumos E, Jovanovic B, Hanumadass M. Nosocomial infections in a burn intensive care unit. Burns 1995;21(3):181-4.
  340. Rodgers GL, Mortensen J, Fisher MC, Lo A, Cresswell A, Long SS. Predictors of infectious complications after burn injuries in children. Pediatr Infect Dis J 2000;19(10):990-5.
  341. Pruitt BA, Jr., McManus AT, Kim SH, Goodwin CW. Burn wound infections: current status. World J Surg 1998;22(2):135-45.
  342. Weber J, ed. Epidemiology of Infections and Strategies for Control in Burn Care and Therapy. St. Louis: Mosby, Inc.; 1998.
  343. Heggers JP, McCoy L, Reisner B, Smith M, Edgar P, Ramirez RJ. Alternate antimicrobial therapy for vancomycin-resistant enterococci burn wound infections. J Burn Care Rehabil 1998;19(5):399-403.
  344. Sheridan RL, Weber J, Benjamin J, Pasternack MS, Tompkins RG. Control of methicillin-resistant Staphylococcus aureus in a pediatric burn unit. Am J Infect Control 1994;22(6):340-5.
  345. Matsumura H, Yoshizawa N, Narumi A, Harunari N, Sugamata A, Watanabe K. Effective control of methicillin-resistant Staphylococcus aureus in a burn unit. Burns 1996;22(4):283-6.
  346. McGregor JC. Profile of the first four years of the Regional Burn Unit based at St. John's Hospital, West Lothian (1992-1996). J R Coll Surg Edinb 1998;43(1):45-8.
  347. Desai MH, Rutan RL, Heggers JP, Herndon DN. Candida infection with and without nystatin prophylaxis. A 11-year experience with patients with burn injury. Arch Surg 1992;127(2):159-62.
  348. Ekenna O, Sherertz RJ, Bingham H. Natural history of bloodstream infections in a burn patient population: the importance of candidemia. Am J Infect Control 1993;21(4):189-95.
  349. Bowser-Wallace BH, Graves DB, Caldwell FT. An epidemiological profile and trend analysis of wound flora in burned children: 7 years' experience. Burns Incl Therm Inj 1984;11(1):16-25.
  350. Tredget EE, Shankowsky HA, Rennie R, Burrell RE, Logsetty S. Pseudomonas infections in the thermally injured patient. Burns 2004;30(1):3-26.
  351. Edgar P, Mlcak R, Desai M, Linares HA, Phillips LG, Heggers JP. Containment of a multiresistant Serratia marcescens outbreak. Burns 1997;23(1):15-8.
  352. Embil JM, McLeod JA, Al-Barrak AM, et al. An outbreak of methicillin resistant Staphylococcus aureus on a burn unit: potential role of contaminated hydrotherapy equipment. Burns 2001;27(7):681-8.
  353. Meier PA, Carter CD, Wallace SE, Hollis RJ, Pfaller MA, Herwaldt LA. A prolonged outbreak of methicillin-resistant Staphylococcus aureus in the burn unit of a tertiary medical center. Infect Control Hosp Epidemiol 1996;17(12):798-802.
  354. Snyder LL, Wiebelhaus P, Boon SE, Morin RA, Goering R. Methicillin-resistant Staphylococcus aureus eradication in a burn center. J Burn Care Rehabil 1993;14(2 Pt 1):164-8.
  355. May AK, Melton SM, McGwin G, Cross JM, Moser SA, Rue LW. Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit. Shock 2000;14(3):259-64.
  356. Sheridan RL, Weber JM, Budkevich LG, Tompkins RG. Candidemia in the pediatric patient with burns. J Burn Care Rehabil 1995;16(4):440-3.
  357. Mayhall CG. The epidemiology of burn wound infections: then and now. Clin Infect Dis 2003;37(4):543-50.
  358. McManus AT, Mason AD, Jr., McManus WF, Pruitt BA, Jr. A decade of reduced gram-negative infections and mortality associated with improved isolation of burned patients. Arch Surg 1994;129(12):1306-9.
  359. Bryce EA, Walker M, Scharf S, et al. An outbreak of cutaneous aspergillosis in a tertiary-care hospital. Infect Control Hosp Epidemiol 1996;17(3):170-2.
  360. Levenson C, Wohlford P, Djou J, Evans S, Zawacki B. Preventing postoperative burn wound aspergillosis. J Burn Care Rehabil 1991;12(2):132-5.
  361. Tredget EE, Shankowsky HA, Joffe AM, et al. Epidemiology of infections with Pseudomonas aeruginosa in burn patients: the role of hydrotherapy. Clin Infect Dis 1992;15(6):941-9.
  362. Wisplinghoff H, Perbix W, Seifert H. Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii: a case-control study of adult burn patients. Clin Infect Dis 1999;28(1):59-66.
  363. Weber JM, Sheridan RL, Schulz JT, Tompkins RG, Ryan CM. Effectiveness of bacteria-controlled nursing units in preventing cross-colonization with resistant bacteria in severely burned children. Infect Control Hosp Epidemiol 2002;23(9):549-51.
  364. Bayat A, Shaaban H, Dodgson A, Dunn KW. Implications for Burns Unit design following outbreak of multi-resistant Acinetobacter infection in ICU and Burns Unit. Burns 2003;29(4):303-6.
  365. Lee JJ, Marvin JA, Heimbach DM, Grube BJ, Engrav LH. Infection control in a burn center. J Burn Care Rehabil 1990;11(6):575-80.
  366. Raymond J, Aujard Y. Nosocomial infections in pediatric patients: a European, multicenter prospective study. European Study Group. Infect Control Hosp Epidemiol 2000;21(4):260-3.
  367. Campins M, Vaque J, Rossello J, et al. Nosocomial infections in pediatric patients: a prevalence study in Spanish hospitals. EPINE Working Group. Am J Infect Control 1993;21(2):58-63.
  368. Allen U, Ford-Jones EL. Nosocomial infections in the pediatric patient: an update. Am J Infect Control 1990;18(3):176-93.
  369. Grohskopf LA, Sinkowitz-Cochran RL, Garrett DO, et al. A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States. J Pediatr 2002;140(4):432-8.
  370. Sohn AH, Garrett DO, Sinkowitz-Cochran RL, et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: Results from the first national point-prevalence survey. J Pediatr 2001;139(6):8217.
  371. Gaynes RP, Edwards JR, Jarvis WR, Culver DH, Tolson JS, Martone WJ. Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1996;98(3 Pt 1):357-61.
  372. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1999;103(4):e39.
  373. Maltezou HC, Drancourt M. Nosocomial influenza in children. J Hosp Infect 2003;55(2):83-91.
  374. Moisiuk SE, Robson D, Klass L, et al. Outbreak of parainfluenza virus type 3 in an intermediate care neonatal nursery. Pediatr Infect Dis J 1998;17(1):49-53.(mj).
  375. Mullins JA, Erdman DD, Weinberg GA, et al. Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg Infect Dis 2004;10(4):700-5.
  376. Hatherill M, Levin M, Lawrenson J, Hsiao NY, Reynolds L, Argent A. Evolution of an adenovirus outbreak in a multidisciplinary children's hospital. J Paediatr Child Health 2004;40(8):449-54.
  377. Langley JM, Hanakowski M. Variation in risk for nosocomial chickenpox after inadvertent exposure. J Hosp Infect 2000;44(3):224-6.
  378. Ratner AJ, Neu N, Jakob K, et al. Nosocomial rotavirus in a pediatric hospital. Infect Control Hosp Epidemiol 2001;22(5):299-301.
  379. Avila-Aguero ML, German G, Paris MM, Herrera JF. Toys in a pediatric hospital: are they a bacterial source? Am J Infect Control 2004;32(5):28790.
  380. Nyqvist KH, Lutes LM. Co-bedding twins: a developmentally supportive care strategy. J Obstet Gynecol Neonatal Nurs 1998;27(4):450-6.
  381. Feldman R, Eidelman AI, Sirota L, Weller A. Comparison of skin-to-skin (kangaroo) and traditional care: parenting outcomes and preterm infant development. Pediatrics 2002;110(1 Pt 1):16-26.
  382. Conde-Agudelo A, Diaz-Rossello JL, Belizan JM. Kangaroo mother care to reduce morbidity and mortality in low birthweight infants. Cochrane Database Syst Rev 2003(2):CD002771.
  383. Adcock PM, Pastor P, Medley F, Patterson JE, Murphy TV. Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis 1998;178(2):577-80.
  384. Shahin R, Johnson IL, Jamieson F, McGeer A, Tolkin J, Ford-Jones EL. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Toronto Child Care Center Study Group. Arch Pediatr Adolesc Med 1999;153(8):864-8.
  385. Stover BH, Duff A, Adams G, Buck G, Hancock G, Rabalais G. Emergence and control of methicillin-resistant Staphylococcus aureus in a children's hospital and pediatric long-term care facility. Am J Infect Control 1992;20(5):248-55.
  386. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279(8):593-8.
  387. CDC. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus--Minnesota and North Dakota, 19971999. MMWR - Morbidity & Mortality Weekly Report 1999;48:707-10.
  388. Abi-Hanna P, Frank AL, Quinn JP, et al. Clonal features of community-acquired methicillin-resistant Staphylococcus aureus in children. Clin Infect Dis 2000;30(3):630-1.
  389. Fergie JE, Purcell K. Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children. Pediatr Infect Dis J 2001;20(9):860-3.
  390. Sattler CA, Mason EO, Jr., Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J 2002;21(10):910-7.
  391. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005;40(12):1785-91.
  392. Jarvis WR. Infection control and changing health-care delivery systems. Emerg Infect Dis 2001;7(2):170-3.
  393. Garibaldi RA. Residential care and the elderly: the burden of infection. J Hosp Infect 1999;43 Suppl:S9-18.
  394. Hsu K, Harris JA. Control of infections in nonacute care pediatric settings. Seminars Pedi Infect Dis 2001;12(2):92-9.
  395. Strausbaugh LJ, Joseph CL. The burden of infection in long-term care. Infect Control Hosp Epidemiol 2000;21(10):674-9.
  396. Centers for Medicare and Medicaid Services. Healthcare Industry Market Update. http://wwwcmshhsgov/reports/hcimu/hcimu_05202003pdf May 2003.
  397. Lee YL, Thrupp LD, Friis RH, Fine M, Maleki P, Cesario TC. Nosocomial infection and antibiotic utilization in geriatric patients: a pilot prospective surveillance program in skilled nursing facilities. Gerontology 1992;38(4):223-32.
  398. Stevenson KB. Regional data set of infection rates for long-term care facilities: description of a valuable benchmarking tool. Am J Infect Control 1999;27(1):20-6.
  399. Jackson MM, Fierer J, Barrett-Connor E, et al. Intensive surveillance for infections in a three-year study of nursing home patients. Am J Epidemiol 1992;135(6):685-96.
  400. Darnowski SB, Gordon M, Simor AE. Two years of infection surveillance in a geriatric long-term care facility. Am J Infect Control 1991;19(4):18590.
  401. Hoffman N, Jenkins R, Putney K. Nosocomial infection rates during a one-year period in a nursing home care unit of a Veterans Administration hospital. Am J Infect Control 1990;18(2):55-63.
  402. Tsan L, Hojlo C, Kearns MA, et al. Infection surveillance and control programs in the Department of Veterans Affairs nursing home care units: a preliminary assessment. Am J Infect Control 2006;34(2):80-3.
  403. Kane RA, Caplan AL, Urv-Wong EK, Freeman IC, Aroskar MA, Finch M. Everyday matters in the lives of nursing home residents: wish for and perception of choice and control. J Am Geriatr Soc 1997;45:1086-93.
  404. Libow LS, Starer P. Care of the nursing home patient. N Engl J Med 1989;321(2):93-6.
  405. Perls TT, Herget M. Higher respiratory infection rates on an Alzheimer's special care unit and successful intervention. J Am Geriatr Soc 1995;43(12):1341-4.
  406. Bradley SF. Issues in the management of resistant bacteria in long-termcare facilities. Infect Control Hosp Epidemiol 1999;20(5):362-6.
  407. Crossley K. Vancomycin-resistant enterococci in long-term-care facilities. Infect Control Hosp Epidemiol 1998;19(7):521-5.
  408. Strausbaugh LJ, Crossley KB, Nurse BA, Thrupp LD. Antimicrobial resistance in long-term-care facilities. Infect Control Hosp Epidemiol 1996;17(2):129-40.
  409. Richards CL. Infections in Long-Term-Care Facilities: Screen or Clean? Infect Control Hosp Epidemiol 2005;26(10):800-01.
  410. Drinka PJ, Krause P, Nest L, Goodman BM, Gravenstein S. Risk of acquiring influenza A in a nursing home from a culture-positive roommate. Infect Control Hosp Epidemiol 2003;24(11):872-4.
  411. Falsey AR, Treanor JJ, Betts RF, Walsh EE. Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. J Am Geriatr Soc 1992;40(2):115-9.
  412. Ellis SE, Coffey CS, Mitchel EF, Jr., Dittus RS, Griffin MR. Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population. J Am Geriatr Soc 2003;51(6):761-7.
  413. Louie JK, Yagi S, Nelson FA, et al. Rhinovirus outbreak in a long term care facility for elderly persons associated with unusually high mortality. Clin Infect Dis 2005;41(2):262-5.
  414. Piednoir E, Bureau-Chalot F, Merle C, Gotzamanis A, Wuibout J, Bajolet O. Direct costs associated with a nosocomial outbreak of adenoviral conjunctivitis infection in a long-term care institution. Am J Infect Control 2002;30(7):407-10.
  415. Addiss DG, Davis JP, Meade BD, et al. A pertussis outbreak in a Wisconsin nursing home. J Infect Dis 1991;164(4):704-10.
  416. Gaynes R, Rimland D, Killum E, et al. Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis 2004;38(5):640-5.
  417. High KP, Bradley S, Loeb M, Palmer R, Quagliarello V, Yoshikawa T. A new paradigm for clinical investigation of infectious syndromes in older adults: assessment of functional status as a risk factor and outcome measure. Clin Infect Dis 2005;40(1):114-22.
  418. Loeb MB, Craven S, McGeer AJ, et al. Risk factors for resistance to antimicrobial agents among nursing home residents. Am J Epidemiol 2003;157(1):40-7.
  419. Vergis EN, Brennen C, Wagener M, Muder RR. Pneumonia in long-term care: a prospective case-control study of risk factors and impact on survival. Arch Intern Med 2001;161(19):2378-81.
  420. Loeb M, McGeer A, McArthur M, Walter S, Simor AE. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med 1999;159(17):2058-64.
  421. Brandeis GH, Ooi WL, Hossain M, Morris JN, Lipsitz LA. A longitudinal study of risk factors associated with the formation of pressure ulcers in nursing homes. J Am Geriatr Soc 1994;42(4):388-93.
  422. Allard JP, Aghdassi E, McArthur M, et al. Nutrition risk factors for survival in the elderly living in Canadian long-term care facilities. J Am Geriatr Soc 2004;52(1):59-65.
  423. Pick N, McDonald A, Bennett N, et al. Pulmonary aspiration in a long-term care setting: clinical and laboratory observations and an analysis of risk factors. J Am Geriatr Soc 1996;44(7):763-8.
  424. Nicolle LE. The chronic indwelling catheter and urinary infection in long-term-care facility residents. Infect Control Hosp Epidemiol 2001;22(5):316-21.
  425. Pien EC, Hume KE, Pien FD. Gastrostomy tube infections in a community hospital. Am J Infect Control 1996;24(5):353-8.
  426. Gomes GF, Pisani JC, Macedo ED, Campos AC. The nasogastric feeding tube as a risk factor for aspiration and aspiration pneumonia. Curr Opin Clin Nutr Metab Care 2003;6(3):327-33.
  427. Bula CJ, Ghilardi G, Wietlisbach V, Petignat C, Francioli P. Infections and functional impairment in nursing home residents: a reciprocal relationship. J Am Geriatr Soc 2004;52(5):700-6.
  428. Bradley SF, Terpenning MS, Ramsey MA, et al. Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med 1991;115(6):417-22.
  429. Washio M, Nishisaka S, Kishikawa K, et al. Incidence of methicillin-resistant Staphylococcus aureus (MRSA) isolation in a skilled nursing home: a third report on the risk factors for the occurrence of MRSA infection in the elderly. J Epidemiol 1996;6(2):69-73.
  430. Trick WE, Weinstein RA, DeMarais PL, et al. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc 2001;49(3):270-6.
  431. Nicolle LE, Garibaldi RA. Infection control in long-term-care facilities. Infect Control Hosp Epidemiol 1995;16(6):348-53.(s).
  432. Crossley K. Long-term care facilities as sources of antibiotic-resistant nosocomial pathogens. Curr Opin Infect Dis 2001;14(4):455-9.
  433. Smith PW, Rusnak PG. Infection prevention and control in the long-termcare facility. SHEA Long-Term-Care Committee and APIC Guidelines Committee. Infect Control Hosp Epidemiol 1997;18(12):831-49.(s).
  434. Friedman C, Barnette M, Buck AS, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in out-ofhospital settings: a consensus panel report. Association for Professionals in Infection Control and Epidemiology and Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 1999;20(10):695-705.
  435. Nicolle LE. Infection control in long-term care facilities. Clin Infect Dis 2000;31(3):752-6.
  436. Bradley SF. Methicillin-resistant Staphylococcus aureus: long-term care concerns. Am J Med 1999;106(5A):2S-10S; discussion 48S-52S.
  437. www.cms.hhs.gov/manuals/Downloads/som107ap_pp_guidelines_ltcf
  438. Mylotte JM, Goodnough S, Tayara A. Antibiotic-resistant organisms among long-term care facility residents on admission to an inpatient geriatrics unit: Retrospective and prospective surveillance. Am J Infect Control 2001;29(3):139-44.
  439. Strausbaugh LJ, Jacobson C, Yost T. Methicillin-resistant Staphylococcus aureus in a nursing home and affiliated hospital: a four-year perspective. Infect Control Hosp Epidemiol 1993;14(6):331-6.
  440. Wiener J, Quinn JP, Bradford PA, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. Jama 1999;281(6):51723.
  441. Pop-Vicas AE, D'Agata EM. The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital. Clin Infect Dis 2005;40(12):1792-8.
  442. Ly N, McCaig LF. National Hospital Ambulatory Medical Care Survey: 2000 outpatient department summary. Adv Data 2002(327):1-27.
  443. Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Adv Data 2002(328):1-32.
  444. Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005;18(1):52-61.
  445. D'Agata EM. Antimicrobial-resistant, Gram-positive bacteria among patients undergoing chronic hemodialysis. Clin Infect Dis 2002;35(10):1212-8.
  446. Goodman RA, Solomon SL. Transmission of infectious diseases in outpatient health care settings. JAMA 1991;265(18):2377-81.
  447. Nafziger DA, Lundstrom T, Chandra S, Massanari RM. Infection control in ambulatory care. Infect Dis Clin North Am 1997;11(2):279-96.
  448. Herwaldt LA, Smith SD, Carter CD. Infection control in the outpatient setting. Infect Control Hosp Epidemiol 1998;19(1):41-74.
  449. Hlady WG, Hopkins RS, Ogilby TE, Allen ST. Patient-to-patient transmission of hepatitis B in a dermatology practice. Am J Public Health 1993;83(12):1689-93.
  450. Birnie GG, Quigley EM, Clements GB, Follet EA, Watkinson G. Endoscopic transmission of hepatitis B virus. Gut 1983;24(2):171-4.
  451. Chant K, Lowe D, Rubin G, et al. Patient-to-patient transmission of HIV in private surgical consulting rooms. Lancet 1993;342(8886-8887):1548-9.
  452. Chant K, Kociuba K, Munro R, et al. Investigation of Possible Patient-to-Patient Transmission of Hepatitis C in a Hospital. NSW Public Health Bull 1994;5(5):47-51.
  453. CDC. Transmission of hepatitis B and C viruses in outpatient settings-New York, Oklahoma, and Nebraska, 2000-2002. MMWR Morb Mortal Wkly Rep 2003;52(38):901-6.
  454. Williams IT, Perz JF, Bell BP. Viral hepatitis transmission in ambulatory health care settings. Clin Infect Dis 2004;38(11):1592-8.
  455. Couldwell DL, Dore GJ, Harkness JL, et al. Nosocomial outbreak of tuberculosis in an outpatient HIV treatment room. Aids 1996;10(5):521-5.
  456. CDC. Mycobacterium tuberculosis Transmission in a Health Clinic -- Florida. MMWR 1989;38(15):256-8; 63-64.
  457. Calder RA, Duclos P, Wilder MH, Pryor VL, Scheel WJ. Mycobacterium tuberculosis transmission in a health clinic. Bull Int Union Tuberc Lung Dis 1991;66(2-3):103-6.
  458. Istre GR, McKee PA, West GR, et al. Measles spread in medical settings: an important focus of disease transmission? Pediatrics 1987;79(3):356-8.
  459. Dawson C, Darrell R. Infections due to adenovirus type 8 in the United States. I. An outbreak of epidemic keratoconjunctivitis originating in a physician's office. N Engl J Med 1963;268:1031-4.
  460. Montessori V, Scharf S, Holland S, Werker DH, Roberts FJ, Bryce E. Epidemic keratoconjunctivitis outbreak at a tertiary referral eye care clinic. Am J Infect Control 1998;26(4):399-405.
  461. Jernigan JA, Lowry BS, Hayden FG, et al. Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control. J Infect Dis 1993;167(6):1307-13.
  462. Buehler JW, Finton RJ, Goodman RA, et al. Epidemic keratoconjunctivitis: report of an outbreak in an ophthalmology practice and recommendations for prevention. Infect Control 1984;5(8):390-4.
  463. Johnston CP, Cooper L, Ruby W, Teeter T, al. E. Community-associated methicillin resistant Staphyloccoccus aureus skin infections among outpatient healthcare workers and its isolation in the clinic environment. Presented at the 15th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (SHEA), Los Angeles, California, 4/10/05. Abstract #132 2005.
  464. Biddick R, Spilker T, Martin A, LiPuma JJ. Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis. FEMS Microbiol Lett 2003;228(1):5762.
  465. Griffiths AL, Jamsen K, Carlin JB, et al. Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic. Am J Respir Crit Care Med 2005;171(9):1020-5.
  466. Danzig LE, Short LJ, Collins K, et al. Bloodstream infections associated with a needleless intravenous infusion system in patients receiving home infusion therapy. JAMA 1995;273(23):1862-4.
  467. Kellerman S, Shay DK, Howard J, et al. Bloodstream infections in home infusion patients: the influence of race and needleless intravascular access devices. J Pediatr 1996;129(5):711-7.
  468. Do AN, Ray BJ, Banerjee SN, et al. Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. J Infect Dis 1999;179(2):442-8.
  469. Tokars JI, Cookson ST, McArthur MA, Boyer CL, McGeer AJ, Jarvis WR. Prospective evaluation of risk factors for bloodstream infection in patients receiving home infusion therapy. Ann Intern Med 1999;131(5):340-7.
  470. Manangan LP, Pearson ML, Tokars JI, Miller E, Jarvis WR. Feasibility of national surveillance of health-care-associated infections in home-care settings. Emerg Infect Dis 2002;8(3):233-6.
  471. Shah SS, Manning ML, Leahy E, Magnusson M, Rheingold SR, Bell LM. Central venous catheter-associated bloodstream infections in pediatric oncology home care. Infect Control Hosp Epidemiol 2002;23(2):99-101.
  472. Gorski LA. Central venous access device outcomes in a homecare agency: a 7-year study. J Infus Nurs 2004;27(2):104-11.
  473. Rosenheimer L, Embry FC, Sanford J, Silver SR. Infection surveillance in home care: device-related incidence rates. Am J Infect Control 1998;26(3):359-63.
  474. White MC, Ragland KE. Surveillance of intravenous catheter-related infections among home care clients. Am J Infect Control 1994;22(4):2315.
  475. Beltrami EM, McArthur MA, McGeer A, et al. The nature and frequency of blood contacts among home healthcare workers. Infect Control Hosp Epidemiol 2000;21(12):765-70.
  476. Embry FC, Chinnes LF. Draft definitions for surveillance of infections in home health care. Am J Infect Control 2000;28(6):449-53.
  477. Fraser TG, Stosor V, Wang Q, Allen A, Zembower TR. Vancomycin and home health care. Emerg Infect Dis 2005;11(10):1558-64.
  478. Carrico RM, Niner S. Multidrug resistant organisms--VRE and MRSA: practical home care tips. Home Healthc Nurse 2002;20(1):23-8; quiz 8-9.
  479. Friedman MM, Rhinehart E. Improving infection control in home care: from ritual to science-based practice. Home Healthc Nurse 2000;18(2):99105; quiz 6.
  480. Friedman MM, Rhinehart E. Putting infection control principles into practice in home care. Nurs Clin North Am 1999;34(2):463-82.
  481. Davis PL, Madigan EA. Evidence-based practice and the home care nurse's bag. Home Healthc Nurse 1999;17(5):295-9.
  482. Sitzman KL, Pett MA, Bloswick DS. An exploratory study of nurse bag use by home visiting nurses. Home Healthc Nurse 2002;20(4):237-43.
  483. Anderson MA, Madigan EA, Helms LB. Nursing research in home health care: endangered species? Home Care Provid 2001;6(6):200-4.
  484. White MC. Identifying infectious diseases in prisons: surveillance, protection, and intervention. West J Med 1999;170(3):177.
  485. Puisis M. Update on public health in correctional facilities. West J Med 1998;169(6):374.
  486. Levy MH, Lerwitworapong J. Issues facing TB control (3.1). Tuberculosis in prisons. Scott Med J 2000;45(5 Suppl):30-2; discussion 3.
  487. Parece MS, Herrera GA, Voigt RF, Middlekauff SL, Irwin KL. STD testing policies and practices in U.S. city and county jails. Sex Transm Dis 1999;26(8):431-7.
  488. Cieslak PR, Curtis MB, Coulombier DM, Hathcock AL, Bean NH, Tauxe RV. Preventable disease in correctional facilities. Desmoteric foodborne outbreaks in the United States, 1974-1991. Arch Intern Med 1996;156(16):1883-8.
  489. CDC. Public health dispatch: tuberculosis outbreak in a homeless population--Portland, Maine, 2002-2003. MMWR Morb Mortal Wkly Rep 2003;52(48):1184.
  490. CDC. Public health dispatch: tuberculosis outbreak among homeless persons--King County, Washington, 2002-2003. MMWR Morb Mortal Wkly Rep 2003;52(49):1209-10.
  491. CDC. Tuberculosis transmission in a homeless shelter population--New York, 2000-2003. MMWR Morb Mortal Wkly Rep 2005;54(6):149-52.
  492. Baillargeon J, Kelley MF, Leach CT, Baillargeon G, Pollock BH. Methicillin-resistant Staphylococcus aureus infection in the Texas prison system. Clin Infect Dis 2004;38(9):e92-5.
  493. Young DM, Harris HW, Charlebois ED, et al. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg 2004;139(9):947-51; discussion 51-3.
  494. Pan ES, Diep BA, Carleton HA, et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin Infect Dis 2003;37(10):1384-8.
  495. CDC. Drug-susceptible tuberculosis outbreak in a state correctional facility housing HIV-infected inmates--South Carolina, 1999-2000. MMWR Morb Mortal Wkly Rep 2000;49(46):1041-4.
  496. CDC. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison--Mississippi, 2000. MMWR Morb Mortal Wkly Rep 2001;50(42):919-22.
  497. Mohle-Boetani JC, Miguelino V, Dewsnup DH, et al. Tuberculosis outbreak in a housing unit for human immunodeficiency virus-infected patients in a correctional facility: transmission risk factors and effective outbreak control. Clin Infect Dis 2002;34(5):668-76.
  498. CDC. Prevention and Control of Tuberculosis in Correctional Facilities. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep 1996;45(RR-8):1-37.
  499. Whimbey E, Englund JA, Couch RB. Community respiratory virus infections in immunocompromised patients with cancer. Am J Med 1997;102(3A):10-8; discussion 25-6.
  500. Zambon M, Bull T, Sadler CJ, Goldman JM, Ward KN. Molecular epidemiology of two consecutive outbreaks of parainfluenza 3 in a bone marrow transplant unit. J Clin Microbiol 1998;36(8):2289-93.
  501. Gamis AS, Howells WB, DeSwarte-Wallace J, Feusner JH, Buckley JD, Woods WG. Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a report from the Children's cancer group study CCG-2891. J Clin Oncol 2000;18(9):1845-55.
  502. Ek T, Mellander L, Andersson B, Abrahamsson J. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group. Pediatr Blood Cancer 2005;44(5):461-8.
  503. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005;201(9):1479-86.
  504. Marchesoni A, Puttini PS, Gorla R, et al. Cyclosporine in addition to infliximab and methotrexate in refractory rheumatoid arthritis. Clin Exp Rheumatol 2005;23(6):916-7.
  505. Isaacs KL, Lewis JD, Sandborn WJ, Sands BE, Targan SR. State of the art: IBD therapy and clinical trials in IBD. Inflamm Bowel Dis 2005;11 Suppl 1:S3-12.
  506. CDC. Guidelines for preventing opportunitic infections among HIV-infected persons. MMWR Morb Mortal Wkly Rep 2002;51 (RR-8):1-52.
  507. Kusne S, and Krystofak S. Infection control issues after solid organ transplantation in transplant infections (Second Edition), ed. Bowden RA, Ljungman P, Paya CV. Lippincott, Williams and Wilkins. Philadelphia; 2003.
  508. Anderson D, DeFor T, Burns L, et al. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections. Biol Blood Marrow Transplant 2003;9(1):52-9.
  509. Pitchford KC, Corey M, Highsmith AK, et al. Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment. J Pediatr 1987;111(2):212-6.
  510. Hamill RJ, Houston ED, Georghiou PR, et al. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med 1995;122(10):762-6.
  511. Hutchinson GR, Parker S, Pryor JA, et al. Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis. J Clin Microbiol 1996;34(3):584-7.
  512. Jakobsson BM, Onnered AB, Hjelte L, Nystrom B. Low bacterial contamination of nebulizers in home treatment of cystic fibrosis patients. J Hosp Infect 1997;36(3):201-7.
  513. Rosenfeld M, Joy P, Nguyen CD, Krzewinski J, Burns JL. Cleaning home nebulizers used by patients with cystic fibrosis: is rinsing with tap water enough? J Hosp Infect 2001;49(3):229-30.
  514. Govan JR. Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex. J R Soc Med 2000;93(Suppl 38):40-5.
  515. Frederiksen B, Koch C, Hoiby N. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr Pulmonol 1999;28(3):159-66.
  516. Isles A, Maclusky I, Corey M, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984;104(2):206-10.
  517. LiPuma JJ. Burkholderia cepacia. Management issues and new insights. Clin Chest Med 1998;19(3):473-86, vi.
  518. Tablan OC, Chorba TL, Schidlow DV, et al. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr 1985;107(3):382-7.
  519. Hudson VL, Wielinski CL, Regelmann WE. Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years. J Pediatr 1993;122(6):854-60.
  520. Farrell PM, Li Z, Kosorok MR, et al. Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis. Am J Respir Crit Care Med 2003;168(9):1100-8.
  521. Smith DL, Gumery LB, Smith EG, Stableforth DE, Kaufmann ME, Pitt TL. Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol 1993;31(11):3017-22.js.
  522. Pegues DA, Schidlow DV, Tablan OC, Carson LA, Clark NC, Jarvis WR. Possible nosocomial transmission of Pseudomonas cepacia in patients with cystic fibrosis. Arch Pediatr Adolesc Med 1994;148(8):805-12.
  523. Govan JR, Brown PH, Maddison J, et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993;342(8862):15-9.
  524. Pegues DA, Carson LA, Tablan OC, et al. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group. J Pediatr 1994;124(5 Pt 1):694-702.
  525. Tablan OC, Martone WJ, Doershuk CF, et al. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest 1987;91(4):527-32.
  526. Thomassen MJ, Demko CA, Doershuk CF, Stern RC, Klinger JD. Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am Rev Respir Dis 1986;134(4):669-71.js.
  527. Weber DJ, Rutala WA. Gene therapy: a new challenge for infection control. Infect Control Hosp Epidemiol 1999;20(8):530-2.
  528. Evans ME, Lesnaw JA. Infection control for gene therapy: a busy physician's primer. Clin Infect Dis 2002;35(5):597-605.
  529. Strausbaugh LJ. Gene therapy and infection control: more light on the way. Infect Control Hosp Epidemiol 2000;21(10):630-2.
  530. CDC. West Nile virus infections in organ transplant recipients--New York and Pennsylvania, August-September, 2005. MMWR Morb Mortal Wkly Rep 2005;54(40):1021-3.
  531. Lawson CA. Cytomegalovirus after kidney transplantation: a case review. Prog Transplant 2005;15(2):157-60.
  532. Tugwell BD, Patel PR, Williams IT, et al. Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med 2005;143(9):648-54.
  533. Kainer MA, Linden JV, Whaley DN, et al. Clostridium infections associated with musculoskeletal-tissue allografts. N Engl J Med 2004;350(25):2564-71.
  534. CDC. Invasive Streptococcus pyogenes after allograft implantation-Colorado, 2003. MMWR Morb Mortal Wkly Rep 2003;52(48):1174-6.
  535. Mungai M, Tegtmeier G, Chamberland M, Parise M. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med 2001;344(26):1973-8.
  536. Lux JZ, Weiss D, Linden JV, et al. Transfusion-associated babesiosis after heart transplant. Emerg Infect Dis 2003;9(1):116-9.
  537. . CDC. Chagas Disease After Organ Transplantation --- United States, 2001. MMWR 2002;51(10):210-2.
  538. CDC. Lymphocytic choriomeningitis virus infection in organ transplant recipients--Massachusetts, Rhode Island, 2005. MMWR Morb Mortal Wkly Rep 2005;54(21):537-9.
  539. Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005;352(11):1103-11.
  540. Gottesdiener KM. Transplanted infections: donor-to-host transmission with the allograft. Ann Intern Med 1989;110(12):1001-16.
  541. Borie DC, Cramer DV, Phan-Thanh L, et al. Microbiological hazards related to xenotransplantation of porcine organs into man. Infect Control Hosp Epidemiol 1998;19(5):355-65.
  542. CDC. U.S. Public Health Service Guideline on Infectious Disease Issues in Xenotransplantation. Centers for Disease Control and Prevention. MMWR - Morbidity & Mortality Weekly Report 2001;50 (RR15)( August):1-46.
  543. IOM. Institute of Medicine. To err is human: building a safer health system. Washington DC National Academy Press; 1999;http://www.iom.edu/report.asp?id=5575.
  544. Gerberding JL. Hospital-onset infections: a patient safety issue. Ann Intern Med 2002;137(8):665-70.
  545. Leape LL, Berwick DM, Bates DW. What practices will most improve safety? Evidence-based medicine meets patient safety. JAMA 2002;288(4):501-7.
  546. Burke JP. Patient safety: infection control - a problem for patient safety. N Engl J Med 2003;348(7):651-6.
  547. Shulman L, Ost D. Managing infection in the critical care unit: how can infection control make the ICU safe? Crit Care Clin 2005;21(1):111-28, ix. 548. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. JAMA 1996;275(3):234-40.
  548. Scheckler WE, Brimhall D, Buck AS, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 1998;19(2):114-24.
  549. www.jointcommission.org/PatientSafety/NationalPatientSafetyGoals/
  550. Jackson M, Chiarello LA, Gaynes RP, Gerberding JL. Nurse staffing and health care-associated infections: Proceedings from a working group meeting. Am J Infect Control 2002;30(4):199-206.
  551. O'Boyle C, Jackson M, Henly SJ. Staffing requirements for infection control programs in US health care facilities: Delphi project. Am J Infect Control 2002;30(6):321-33.
  552. Peterson LR, Hamilton JD, Baron EJ, et al. Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health care. Clin Infect Dis 2001;32(4):605-11.
  553. McGowan JE, Jr., Tenover FC. Confronting bacterial resistance in healthcare settings: a crucial role for microbiologists. Nat Rev Microbiol 2004;2(3):251-8.
  554. . (Accessed at
  555. Curtis JR, Cook DJ, Wall RJ, et al. Intensive care unit quality improvement: a "how-to" guide for the interdisciplinary team. Crit Care Med 2006;34(1):211-8.
  556. Pronovost PJ, Nolan T, Zeger S, Miller M, Rubin H. How can clinicians measure safety and quality in acute care? Lancet 2004;363(9414):1061-7.
  557. Goldrick BA, Dingle DA, Gilmore GK, Curchoe RM, Plackner CL, Fabrey LJ. Practice analysis for infection control and epidemiology in the new millennium. Am J Infect Control 2002;30(8):437-48.
  558. CDC. Guideline for Hand Hygiene in Health-Care Settings: Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR 2002;51(16)(RR-16):1-44.
  559. Bonomo RA, Rice LB. Emerging issues in antibiotic resistant infections in long-term care facilities. J Gerontol A Biol Sci Med Sci 1999;54(6):B2607.
  560. Larson EL, Early E, Cloonan P, Sugrue S, Parides M. An organizational climate intervention associated with increased handwashing and decreased nosocomial infections. Behav Med 2000;26(1):14-22.
  561. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 2000;356(9238):1307-12.
  562. Murthy R. Implementation of strategies to control antimicrobial resistance. Chest 2001;119(2 Suppl):405S-11S.
  563. Rondeau KV, Wagar TH. Organizational learning and continuous quality improvement: examining the impact on nursing home performance. Healthc Manage Forum 2002;15(2):17-23.
  564. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA 2003;290(14):1899-905.
  565. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121(2):182-205.
  566. McArthur BJ, Pugliese G, Weinstein S, et al. A national task analysis of infection control practitioners, 1982. Part One: methodology and demography. Am J Infect Control 1984;12(2):88-95.
  567. Shannon R, McArthur BJ, Weinstein S, et al. A national task analysis of infection control practitioners, 1982. Part Two: Tasks, knowledge, and abilities for practice. Am J Infect Control 1984;12(3):187-96.
  568. Pugliese G, McArthur BJ, Weinstein S, et al. A national task analysis of infection control practitioners, 1982. Part Three: The relationship between hospital size and tasks performed. Am J Infect Control 1984;12(4):221-7.
  569. Larson E, Eisenberg R, Soule BM. Validating the certification process for infection control practice. Am J Infect Control 1988;16(5):198-205.
  570. Bjerke NB, Fabrey LJ, Johnson CB, et al. Job analysis 1992: infection control practitioner. Am J Infect Control 1993;21(2):51-7.
  571. Turner JG, Kolenc KM, Docken L. Job analysis 1996: Infection control professional. Certification Board in Infection Control and Epidemiology, Inc, 1996 Job Analysis Committee. Am J Infect Control 1999;27(2):14557.
  572. Health Canada. Nosocomial and Occupational Infections Section. Development of a resource model for infection prevention and control programs in acute, long term, and home care settings: conference proceedings of the Infection Prevention and Control Alliance. AJIC 2004;32:2-6.
  573. Lee TH, Meyer GS, Brennan TA. A middle ground on public accountability. N Engl J Med 2004;350(23):2409-12.
  574. Stevenson KB, Murphy CL, Samore MH, et al. Assessing the status of infection control programs in small rural hospitals in the western United States. Am J Infect Control 2004;32(5):255-61.
  575. Simonds DN, Horan TC, Kelley R, Jarvis WR. Detecting pediatric nosocomial infections: how do infection control and quality assurance personnel compare? Am J Infect Control 1997;25(3):202-8.
  576. Dawson SJ. The role of the infection control link nurse. J Hosp Infect 2003;54(4):251-7; quiz 320.
  577. Wright J, Stover BH, Wilkerson S, Bratcher D. Expanding the infection control team: development of the infection control liaison position for the neonatal intensive care unit. Am J Infect Control 2002;30(3):174-8.
  578. Teare EL, Peacock A. The development of an infection control link-nurse programme in a district general hospital. J Hosp Infect 1996;34(4):267-78.
  579. Ching TY, Seto WH. Evaluating the efficacy of the infection control liaison nurse in the hospital. J Adv Nurs 1990;15(10):1128-31.
  580. Amundsen J, Drennan DP. An infection control nurse-advisor program. Am J Infect Control 1983;11(1):20-3.
  581. Ross KA. A program for infection surveillance utilizing an infection control liaison nurse. Am J Infect Control 1982;10(1):24-8.
  582. Needleman J, Buerhaus P, Mattke S, Stewart M, Zelevinsky K. Nurse-staffing levels and the quality of care in hospitals. N Engl J Med 2002;346(22):1715-22.
  583. Needleman J, Buerhaus P, Mattke S, Stewart M, Zelevinsky K. Nurse-staffing levels and the quality of care in hospitals. N Engl J Med 2002;346(22):1715-22.
  584. Dimick JB, Swoboda SM, Pronovost PJ, Lipsett PA. Effect of nurse-topatient ratio in the intensive care unit on pulmonary complications and resource use after hepatectomy. Am J Crit Care 2001;10(6):376-82.
  585. Mayhall CG, Lamb VA, Gayle WE, Jr., Haynes BW, Jr. Enterobacter cloacae septicemia in a burn center: epidemiology and control of an outbreak. J Infect Dis 1979;139(2):166-71.
  586. Goldmann DA, Durbin WA, Jr., Freeman J. Nosocomial infections in a neonatal intensive care unit. J Infect Dis 1981;144(5):449-59.(mj).
  587. Arnow P, Allyn PA, Nichols EM, Hill DL, Pezzlo M, Bartlett RH. Control of methicillin-resistant Staphylococcus aureus in a burn unit: role of nurse staffing. J Trauma 1982;22(11):954-9.
  588. Haley RW, Bregman DA. The role of understaffing and overcrowding in recurrent outbreaks of staphylococcal infection in a neonatal special-care unit. J Infect Dis 1982;145(6):875-85.
  589. Fridkin SK, Pear SM, Williamson TH, Galgiani JN, Jarvis WR. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 1996;17(3):150-8.
  590. Robert J, Fridkin SK, Blumberg HM, et al. The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit. Infect Control Hosp Epidemiol 2000;21(1):12-7.(mj).
  591. Li J, Birkhead GS, Strogatz DS, Coles FB. Impact of institution size, staffing patterns, and infection control practices on communicable disease outbreaks in New York State nursing homes. Am J Epidemiol 1996;143(10):1042-9.
  592. Archibald LK, Manning ML, Bell LM, Banerjee S, Jarvis WR. Patient density, nurse-to-patient ratio and nosocomial infection risk in a pediatric cardiac intensive care unit. Pediatr Infect Dis J 1997;16(11):1045-8.
  593. Harbarth S, Sudre P, Dharan S, Cadenas M, Pittet D. Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices. Infect Control Hosp Epidemiol 1999;20(9):598-603.
  594. Vicca AF. Nursing staff workload as a determinant of methicillin-resistant Staphylococcus aureus spread in an adult intensive therapy unit. J Hosp Infect 1999;43(2):109-13.
  595. Stegenga J, Bell E, Matlow A. The role of nurse understaffing in nosocomial viral gastrointestinal infections on a general pediatrics ward. Infect Control Hosp Epidemiol 2002;23(3):133-6.
  596. Alonso-Echanove J, Edwards JR, Richards MJ, et al. Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units. Infect Control Hosp Epidemiol 2003;24(12):916-25.
  597. Petrosillo N, Gilli P, Serraino D, et al. Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis 2001;37(5):1004-10.
  598. Pfaller MA, Herwaldt LA. The clinical microbiology laboratory and infection control: emerging pathogens, antimicrobial resistance, and new technology. Clin Infect Dis 1997;25(4):858-70.
  599. Simor AE. The role of the laboratory in infection prevention and control programs in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol 2001;22(7):459-63.
  600. Weinstein RA, Mallison GF. The role of the microbiology laboratory in surveillance and control of nosocomial infections. Am J Clin Pathol 1978;69(2):130-6.
  601. Kolmos HJ. Interaction between the microbiology laboratory and clinician: what the microbiologist can provide. J Hosp Infect 1999;43 Suppl:S285-91.
  602. Clinical and Laboratory Standards Institute. www.clsi.org/
  603. Ginocchio CC. Role of NCCLS in antimicrobial susceptibility testing and monitoring. Am J Health Syst Pharm 2002;59(8 Suppl 3):S7-11.
  604. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; twelfth informational supplement. Document M100-S12. NCCLS, Wayne (PA) 2002.
  605. NCCLS. (2002). Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data. Approved Guideline. NCCLS document M39-A (ISBN 1-56238-422-9). Wayne: PA, NCCLS. 2002.
  606. Halstead DC, Gomez N, McCarter YS. Reality of developing a community-wide antibiogram. J Clin Microbiol 2004;42(1):1-6.
  607. Ernst EJ, Diekema DJ, BootsMiller BJ, et al. Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data? Diagn Microbiol Infect Dis 2004;49(2):141-5.
  608. Bergeron MG, Ouellette M. Preventing antibiotic resistance through rapid genotypic identification of bacteria and of their antibiotic resistance genes in the clinical microbiology laboratory. J Clin Microbiol 1998;36(8):216972.
  609. Hacek DM, Suriano T, Noskin GA, Kruszynski J, Reisberg B, Peterson LR. Medical and economic benefit of a comprehensive infection control program that includes routine determination of microbial clonality. Am J Clin Pathol 1999;111(5):647-54.
  610. Rodriguez WJ, Schwartz RH, Thorne MM. Evaluation of diagnostic tests for influenza in a pediatric practice. Pediatr Infect Dis J 2002;21(3):193-6.
  611. CDC. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005;54(RR-8):1-40.
  612. Uyeki TM. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J 2003;22(2):164-77.
  613. Chan EL, Antonishyn N, McDonald R, et al. The use of TaqMan PCR assay for detection of Bordetella pertussis infection from clinical specimens. Arch Pathol Lab Med 2002;126(2):173-6.
  614. Barenfanger J, Drake C, Kacich G. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 1999;37(5):1415-8.
  615. Barenfanger J, Drake C, Leon N, Mueller T, Troutt T. Clinical and financial benefits of rapid detection of respiratory viruses: an outcomes study. J Clin Microbiol 2000;38(8):2824-8.
  616. Ramers C, Billman G, Hartin M, Ho S, Sawyer MH. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA 2000;283(20):2680-5.
  617. Mackie PL, Joannidis PA, Beattie J. Evaluation of an acute point-of-care system screening for respiratory syncytial virus infection. J Hosp Infect 2001;48(1):66-71.
  618. Guillemot D, Courvalin P. Better control of antibiotic resistance. Clin Infect Dis 2001;33(4):542-7.
  619. Paterson DL. The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. Clin Infect Dis 2006;42 Suppl 2:S90-5.
  620. Lundstrom T, Pugliese G, Bartley J, Cox J, Guither C. Organizational and environmental factors that affect worker health and safety and patient outcomes. Am J Infect Control 2002;30(2):93-106.
  621. www.patientsafety.com/vision.html
  622. Pronovost PJ, Jenckes MW, Dorman T, et al. Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery. JAMA 1999;281(14):1310-7.
  623. Pronovost PJ, Angus DC, Dorman T, Robinson KA, Dremsizov TT, Young TL. Physician staffing patterns and clinical outcomes in critically ill patients: a systematic review. JAMA 2002;288(17):2151-62.
  624. Pronovost PJ, Weast B, Holzmueller CG, et al. Evaluation of the culture of safety: survey of clinicians and managers in an academic medical center. Qual Saf Health Care 2003;12(6):405-10.
  625. Nieva VF, Sorra J. Safety culture assessment: a tool for improving patient safety in healthcare organizations. Qual Saf Health Care 2003;12 Suppl 2:ii17-23.
  626. Clarke SP, Rockett JL, Sloane DM, Aiken LH. Organizational climate, staffing, and safety equipment as predictors of needlestick injuries and near-misses in hospital nurses. Am J Infect Control 2002;30(4):207-16.
  627. Rivers DL, Aday LA, Frankowski RF, Felknor S, White D, Nichols B. Predictors of nurses' acceptance of an intravenous catheter safety device. Nurs Res 2003;52(4):249-55.
  628. Gershon RR, Karkashian CD, Grosch JW, et al. Hospital safety climate and its relationship with safe work practices and workplace exposure incidents. Am J Infect Control 2000;28(3):211-21.
  629. Gershon RR, Vlahov D, Felknor SA, et al. Compliance with universal precautions among health care workers at three regional hospitals. Am J Infect Control 1995;23(4):225-36.
  630. Michalsen A, Delclos GL, Felknor SA, et al. Compliance with universal precautions among physicians. J Occup Environ Med 1997;39(2):130-7.
  631. Vaughn TE, McCoy KD, Beekmann SE, Woolson RE, Torner JC, Doebbeling BN. Factors promoting consistent adherence to safe needle precautions among hospital workers. Infect Control Hosp Epidemiol 2004;25(7):548-55.
  632. Grosch JW, Gershon RR, Murphy LR, DeJoy DM. Safety climate dimensions associated with occupational exposure to blood-borne pathogens in nurses. Am J Ind Med 1999;Suppl 1:122-4.
  633. Piotrowski MM, Hinshaw DB. The safety checklist program: creating a culture of safety in intensive care units. Jt Comm J Qual Improv 2002;28(6):306-15.
  634. Weeks WB, Bagian JP. Developing a culture of safety in the Veterans Health Administration. Eff Clin Pract 2000;3(6):270-6.
  635. Bagian JP, Gosbee JW. Developing a culture of patient safety at the VA. Ambul Outreach 2000:25-9.
  636. Tokars JI, McKinley GF, Otten J, et al. Use and efficacy of tuberculosis infection control practices at hospitals with previous outbreaks of multidrug-resistant tuberculosis. Infect Control Hosp Epidemiol 2001;22(7):449-55.
  637. Maloney SA, Pearson ML, Gordon MT, Del Castillo R, Boyle JF, Jarvis WR. Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers. Ann Intern Med 1995;122(2):90-5.
  638. Montecalvo MA, Jarvis WR, Uman J, et al. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med 1999;131(4):269-72.
  639. Sherertz RJ, Ely EW, Westbrook DM, et al. Education of physicians-intraining can decrease the risk for vascular catheter infection. Ann Intern Med 2000;132(8):641-8.
  640. Lynch P, Cummings MJ, Roberts PL, Herriott MJ, Yates B, Stamm WE. Implementing and evaluating a system of generic infection precautions: body substance isolation. Am J Infect Control 1990;18(1):1-12.
  641. Kelen GD, DiGiovanna TA, Celentano DD, et al. Adherence to Universal (barrier) Precautions during interventions on critically ill and injured emergency department patients. J Acquir Immune Defic Syndr 1990;3(10):987-94.
  642. Courington KR, Patterson SL, Howard RJ. Universal precautions are not universally followed. Arch Surg 1991;126(1):93-6.
  643. Kaczmarek RG, Moore RM, Jr., McCrohan J, et al. Glove use by health care workers: results of a tristate investigation. Am J Infect Control 1991;19(5):228-32.
  644. Freeman SW, Chambers CV. Compliance with universal precautions in a medical practice with a high rate of HIV infection. J Am Board Fam Pract 1992;5(3):313-8.
  645. Friedland LR, Joffe M, Wiley JF, 2nd, Schapire A, Moore DF. Effect of educational program on compliance with glove use in a pediatric emergency department. Am J Dis Child 1992;146(11):1355-8.
  646. Henry K, Campbell S, Maki M. A comparison of observed and self-reported compliance with universal precautions among emergency department personnel at a Minnesota public teaching hospital: implications for assessing infection control programs. Ann Emerg Med 1992;21(8):940-6.
  647. Henry K, Campbell S, Collier P, Williams CO. Compliance with universal precautions and needle handling and disposal practices among emergency department staff at two community hospitals. Am J Infect Control 1994;22(3):129-37.
  648. Eustis TC, Wright SW, Wrenn KD, Fowlie EJ, Slovis CM. Compliance with recommendations for universal precautions among prehospital providers. Ann Emerg Med 1995;25(4):512-5.
  649. DiGiacomo JC, Hoff WS, Rotondo MF, et al. Barrier precautions in trauma resuscitation: real-time analysis utilizing videotape review. Am J Emerg Med 1997;15(1):34-9.
  650. Thompson BL, Dwyer DM, Ussery XT, Denman S, Vacek P, Schwartz B. Handwashing and glove use in a long-term-care facility. Infect Control Hosp Epidemiol 1997;18(2):97-103.(s).
  651. Helfgott AW, Taylor-Burton J, Garcini FJ, Eriksen NL, Grimes R. Compliance with universal precautions: knowledge and behavior of residents and students in a department of obstetrics and gynecology. Infect Dis Obstet Gynecol 1998;6(3):123-8.
  652. Moore S, Goodwin H, Grossberg R, Toltzis P. Compliance with universal precautions among pediatric residents. Arch Pediatr Adolesc Med 1998;152(6):554-7.
  653. Akduman D, Kim LE, Parks RL, et al. Use of personal protective equipment and operating room behaviors in four surgical subspecialties: personal protective equipment and behaviors in surgery. Infect Control Hosp Epidemiol 1999;20(2):110-4.
  654. Brooks AJ, Phipson M, Potgieter A, Koertzen H, Boffard KD. Education of the trauma team: video evaluation of the compliance with universal barrier precautions in resuscitation. Eur J Surg 1999;165(12):1125-8.
  655. Kidd F, Heitkemper P, Kressel AB. A comprehensive educational approach to improving patient isolation practice. Clin Perform Qual Health Care 1999;7(2):74-6.
  656. Madan AK, Rentz DE, Wahle MJ, Flint LM. Noncompliance of health care workers with universal precautions during trauma resuscitations. South Med J 2001;94(3):277-80.
  657. Madan AK, Raafat A, Hunt JP, Rentz D, Wahle MJ, Flint LM. Barrier precautions in trauma: is knowledge enough? J Trauma 2002;52(3):540-3.
  658. Jeffe DB, Mutha S, Kim LE, Evanoff BA, Fraser VJ. Evaluation of a preclinical, educational and skills-training program to improve students' use of blood and body fluid precautions: one-year follow-up. Prev Med 1999;29(5):365-73.
  659. Williams CO, Campbell S, Henry K, Collier P. Variables influencing worker compliance with universal precautions in the emergency department. Am J Infect Control 1994;22(3):138-48.
  660. Larson E, McGeer A, Quraishi ZA, et al. Effect of an automated sink on handwashing practices and attitudes in high-risk units. Infect Control Hosp Epidemiol 1991;12(7):422-8.
  661. Swoboda SM, Earsing K, Strauss K, Lane S, Lipsett PA. Electronic monitoring and voice prompts improve hand hygiene and decrease nosocomial infections in an intermediate care unit. Crit Care Med 2004;32(2):358-63.
  662. Kretzer EK, Larson EL. Behavioral interventions to improve infection control practices. Am J Infect Control 1998;26(3):245-53.
  663. CDC. Updated Guidelines for Evaluating Public Health Surveillance Systems. Recommendations from the Guidelines Working Group. MMWR Recomm Rep 2001;50(RR-13):1-35.
  664. Semmelweiss IP. Die aetiologie, der begriff und die prophylaxis des kindbettfiebers. Pest, Wein, und Leipzig:. CA Harleben's Verlags-Expedition 1861.
  665. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004 Jun 15;38:1706-15.
  666. Bloom BT, Craddock A, Delmore PM, et al. Reducing acquired infections in the NICU: observing and implementing meaningful differences in process between high and low acquired infection rate centers. J Perinatol 2003;23:489-92.
  667. Braun BI, Kritchevsky SB, Wong ES, et al. Preventing central venous catheter-associated primary bloodstream infections: characteristics of practices among hospitals participating in the Evaluation of Processes and Indicators in Infection Control (EPIC) study. Infect Control Hosp Epidemiol 2003;24(12):926-35.
  668. Baker OG. Process surveillance: an epidemiologic challenge for all health care organizations. AJIC 1997;25:96-101.
  669. Loeb M, McGeer A, McArthur M, Peeling RW, Petric M, Simor AE. Surveillance for outbreaks of respiratory tract infections in nursing homes. Cmaj 2000;162(8):1133-7.
  670. Nicolle LE. Preventing infections in non-hospital settings: long-term care. Emerg Infect Dis 2001;7(2):205-7.
  671. Pottinger JM, Herwaldt LA, Perl TM. Basics of surveillance--an overview. Infect Control Hosp Epidemiol 1997;18(7):513-27.
  672. Lee TB, Baker OG, Lee JT, Scheckler WE, Steele L, Laxton CE. Recommended practices for surveillance. Association for Professionals in Infection Control and Epidemiology, Inc. Surveillance Initiative working Group. Am J Infect Control 1998;26(3):277-88.
  673. Haley RW. The scientific basis for using surveillance and risk factor data to reduce nosocomial infection rates. J Hosp Infect 1995;30 Suppl:3-14.
  674. Benneyan JC, Lloyd RC, Plsek PE. Statistical process control as a tool for research and healthcare improvement. Qual Saf Health Care 2003;12(6):458-64.
  675. Lemmen SW, Zolldann D, Gastmeier P, Lutticken R. Implementing and evaluating a rotating surveillance system and infection control guidelines in 4 intensive care units. Am J Infect Control 2001;29(2):89-93.
  676. Gaynes R, Richards C, Edwards J, et al. Feeding back surveillance data to prevent hospital-acquired infections. Emerg Infect Dis 2001;7(2):295-8.
  677. Tokars JI, Richards C, Andrus M, et al. The changing face of surveillance for health care-associated infections. Clin Infect Dis 2004;39:1347-52.
  678. Sands KE, Yokoe DS, Hooper DC, et al. Detection of postoperative surgical-site infections: comparison of health plan-based surveillance with hospital-based programs. Infect Control Hosp Epidemiol 2003;24(10):741-3.
  679. Jodra VM, Rodela AR, Martinez EM, Fresnena NL. Standardized infection ratios for three general surgery procedures: a comparison between Spanish hospitals and U.S. centers participating in the National Nosocomial Infections Surveillance System. Infect Control Hosp Epidemiol 2003;24(10):744-8.
  680. McKibben L, Horan T, Tokars JI, et al. Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Am J Infect Control 2005;33(4):217-26.
  681. Gould D, Chamberlain A. The use of a ward-based educational teaching package to enhance nurses' compliance with infection control procedures. J Clin Nurs 1997;6(1):55-67.
  682. Calabro K, Weltge A, Parnell S, Kouzekanani K, Ramirez E. Intervention for medical students: effective infection control. Am J Infect Control 1998;26(4):431-6.
  683. Haiduven DJ, Hench CP, Simpkins SM, Stevens DA. Standardized management of patients and employees exposed to pertussis. Infect Control Hosp Epidemiol 1998;19(11):861-4.
  684. Macartney KK, Gorelick MH, Manning ML, Hodinka RL, Bell LM. Nosocomial respiratory syncytial virus infections: the cost- effectiveness and cost-benefit of infection control. Pediatrics 2000;106(3):520-6.
  685. Beekmann SE, Vaughn TE, McCoy KD, et al. Hospital bloodborne pathogens programs: program characteristics and blood and body fluid exposure rates. Infect Control Hosp Epidemiol 2001;22(2):73-82.
  686. Sokas RK, Simmens S, Scott J. A training program in universal precautions for second-year medical students. Acad Med 1993;68(5):3746.
  687. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001;344(19):1427-33.
  688. Bonten MJ, Kollef MH, Hall JB. Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis 2004;38(8):1141-9.
  689. Lau JT, Fung KS, Wong TW, et al. SARS transmission among hospital workers in Hong Kong. Emerg Infect Dis 2004;10(2):280-6.
  690. Talbot TR, Bradley SE, Cosgrove SE, Ruef C, Siegel JD, Weber DJ. Influenza vaccination of healthcare workers and vaccine allocation for healthcare workers during vaccine shortages. Infect Control Hosp Epidemiol 2005;26(11):882-90.
  691. Harbarth S, Siegrist CA, Schira JC, Wunderli W, Pittet D. Influenza immunization: improving compliance of healthcare workers. Infect Control Hosp Epidemiol 1998;19(5):337-42.
  692. Bryant KA, Stover B, Cain L, Levine GL, Siegel J, Jarvis WR. Improving influenza immunization rates among healthcare workers caring for high-risk pediatric patients. Infect Control Hosp Epidemiol 2004;25(11):912-7.
  693. Martinello RA, Jones L, Topal JE. Correlation between healthcare workers' knowledge of influenza vaccine and vaccine receipt. Infect Control Hosp Epidemiol 2003;24(11):845-7.
  694. Goldrick B, Gruendemann B, Larson E. Learning styles and teaching/learning strategy preferences: implications for educating nurses in critical care, the operating room, and infection control. Heart Lung 1993;22(2):176-82.
  695. Davis D, O'Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? JAMA 1999;282(9):867-74.
  696. Carr H, and Hinson P. Education and Training. ed. APIC Text of Infection Control and Epidemiology. 2nd edition. Washington, DC: Association for Professionals in Infection Control and Epidemiology, Inc. (APIC); pp. 11-1; 2005.
  697. Caffarella RS. Planning Programs for Adult Learners: A Practical Guide for Educators, Trainers, and Staff Developers, Second Edition. In. San Francisco: Jossey-Bass; 2001.
  698. Sargeant J, Curran V, Jarvis-Selinger S, et al. Interactive on-line continuing medical education: physicians' perceptions and experiences. J Contin Educ Health Prof 2004;24(4):227-36.
  699. Van Harrison R. Systems-based framework for continuing medical education and improvements in translating new knowledge into physicians' practices. J Contin Educ Health Prof 2004;24 Suppl 1:S50-62.
  700. Cole TB, Glass RM. Learning associated with participation in journal-based continuing medical education. J Contin Educ Health Prof 2004;24(4):205-12.
  701. Diekema DJ, Albanese MA, Schuldt SS, Doebbeling BN. Blood and body fluid exposures during clinical training: relation to knowledge of universal precautions. J Gen Intern Med 1996;11(2):109-11.
  702. Diekema DJ, Schuldt SS, Albanese MA, Doebbeling BN. Universal precautions training of preclinical students: impact on knowledge, attitudes, and compliance. Prev Med 1995;24(6):580-5.
  703. Warren DK, Zack JE, Cox MJ, Cohen MM, Fraser VJ. An educational intervention to prevent catheter-associated bloodstream infections in a nonteaching, community medical center. Crit Care Med 2003;31(7):195963.
  704. Dubbert PM, Dolce J, Richter W, Miller M, Chapman SW. Increasing ICU staff handwashing: effects of education and group feedback. Infect Control Hosp Epidemiol 1990;11(4):191-3.
  705. Avila-Aguero ML, Umana MA, Jimenez AL, Faingezicht I, Paris MM. Handwashing practices in a tertiary-care, pediatric hospital and the effect on an educational program. Clin Perform Qual Health Care 1998;6(2):702.
  706. Lai KK, Fontecchio SA, Kelley AL, Melvin ZS. Knowledge of the transmission of tuberculosis and infection control measures for tuberculosis among healthcare workers. Infect Control Hosp Epidemiol 1996;17(3):168-70.
  707. Koenig S, Chu J. Senior medical students' knowledge of universal precautions. Acad Med 1993;68(5):372-4.
  708. Babcock HM, Zack JE, Garrison T, et al. An educational intervention to reduce ventilator-associated pneumonia in an integrated health system: a comparison of effects. Chest 2004;125(6):2224-31.
  709. McGuckin M, Taylor A, Martin V, Porten L, Salcido R. Evaluation of a patient education model for increasing hand hygiene compliance in an inpatient rehabilitation unit. Am J Infect Control 2004;32(4):235-8.
  710. Cirone N. Patient-education handbook. Nursing 1997;27(8):44-5.
  711. Chase TM. Learning styles and teaching strategies: enhancing the patient education experience. SCI Nurse 2001;18:138-41.
  712. Jarvis WR. Handwashing--the Semmelweis lesson forgotten? Lancet 1994;344(8933):1311-2.
  713. Daniels IR, Rees BI. Handwashing: simple, but effective. Ann R Coll Surg Engl 1999;81:117-8.
  714. Webster J, Faoagali JL, Cartwright D. Elimination of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan. J Paediatr Child Health 1994;30(1):59-64.
  715. Zafar AB, Butler RC, Reese DJ, Gaydos LA, Mennonna PA. Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 1995;23(3):200-8.
  716. Malik RK, Montecalvo MA, Reale MR, et al. Epidemiology and control of vancomycin-resistant enterococci in a regional neonatal intensive care unit. Pediatr Infect Dis J 1999;18(4):352-6.
  717. Pittet D, Boyce JM. Hand hygiene and patient care: pursuing the Semmelweis legacy. Lancet Infect Dis 2001:9-20.
  718. Lin CM, Wu FM, Kim HK, Doyle MP, Michael BS, Williams LK. A comparison of hand washing techniques to remove Escherichia coli and caliciviruses under natural or artificial fingernails. J Food Prot 2003;66(12):2296-301.
  719. Edel E, Houston S, Kennedy V, LaRocco M. Impact of a 5-minute scrub on the microbial flora found on artificial, polished, or natural fingernails of operating room personnel. Nurs Res 1998;47(1):54-9.
  720. Pottinger J, Burns S, Manske C. Bacterial carriage by artificial versus natural nails. Am J Infect Control 1989;17(6):340-4.
  721. Hedderwick SA, McNeil SA, Lyons MJ, Kauffman CA. Pathogenic organisms associated with artificial fingernails worn by healthcare workers. Infect Control Hosp Epidemiol 2000;21(8):505-9.
  722. Passaro DJ, Waring L, Armstrong R, et al. Postoperative Serratia marcescens wound infections traced to an out-of- hospital source. J Infect Dis 1997;175(4):992-5.
  723. Moolenaar RL, Crutcher JM, San Joaquin VH, et al. A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? Infect Control Hosp Epidemiol 2000;21(2):80-5.
  724. Parry MF, Grant B, Yukna M, et al. Candida osteomyelitis and diskitis after spinal surgery: an outbreak that implicates artificial nail use. Clin Infect Dis 2001;32(3):352-7.
  725. Boszczowski I, Nicoletti C, Puccini DM, et al. Outbreak of extended spectrum beta-lactamase-producing Klebsiella pneumoniae infection in a neonatal intensive care unit related to onychomycosis in a health care worker. Pediatr Infect Dis J 2005;24(7):648-50.
  726. Trick WE, Vernon MO, Hayes RA, et al. Impact of ring wearing on hand contamination and comparison of hand hygiene agents in a hospital. Clin Infect Dis 2003;36(11):1383-90.
  727. Pittet D, Dharan S, Touveneau S, Sauvan V, Perneger TV. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med 1999;159(8):821-6.
  728. Tenorio AR, Badri SM, Sahgal NB, et al. Effectiveness of gloves in the prevention of hand carriage of vancomycin-resistant enterococcus species by health care workers after patient care. Clin Infect Dis 2001;32(5):8269.( s).
  729. Mast ST, Woolwine JD, Gerberding JL. Efficacy of gloves in reducing blood volumes transferred during simulated needlestick injury. J Infect Dis 1993;168(6):1589-92.
  730. Medical Glove Guidance Manual. www.fda.gov/cdrh/dsma/gloveman/gloveman99.pdf
  731. Korniewicz DM, El-Masri M, Broyles JM, Martin CD, O'Connell K P. Performance of latex and nonlatex medical examination gloves during simulated use. Am J Infect Control 2002;30(2):133-8.
  732. Korniewicz DM, McLeskey SW. Latex allergy and gloving standards. Semin Perioper Nurs 1998;7(4):216-21.
  733. Ranta PM, Ownby DR. A review of natural-rubber latex allergy in health care workers. Clin Infect Dis 2004;38(2):252-6.
  734. Korniewicz DM, Kirwin M, Cresci K, et al. Barrier protection with examination gloves: double versus single. Am J Infect Control 1994;22(1):12-5.
  735. Korniewicz DM, Kirwin M, Cresci K, Larson E. Leakage of latex and vinyl exam gloves in high and low risk clinical settings. Am Ind Hyg Assoc J 1993;54(1):22-6.
  736. Rego A, Roley L. In-use barrier integrity of gloves: latex and nitrile superior to vinyl. Am J Infect Control 1999;27(5):405-10.
  737. Kotilainen HR, Brinker JP, Avato JL, Gantz NM. Latex and vinyl examination gloves. Quality control procedures and implications for health care workers. Arch Intern Med 1989;149(12):2749-53.
  738. Korniewicz DM, Laughon BE, Butz A, Larson E. Integrity of vinyl and latex procedure gloves. Nurs Res 1989;38(3):144-6.
  739. OSHA. OSHA. Department of Labor: Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens: Final rule. 29 CFR Part 1910:1030 Federal Register 1991;56:64003-64182 Revised 2001 CFR 66 2001:5317-25.
  740. CDC. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 1995;44 (RR12): 1-13.
  741. Olsen RJ, Lynch P, Coyle MB, Cummings J, Bokete T, Stamm WE. Examination gloves as barriers to hand contamination in clinical practice. JAMA 1993;270(3):350-3.
  742. Doebbeling BN, Pfaller MA, Houston AK, Wenzel RP. Removal of nosocomial pathogens from the contaminated glove. Implications for glove reuse and handwashing. Ann Intern Med 1988;109(5):394-8.
  743. Maki DG, McCormick RD, Zilz MA, et al. A MRSA outbreak in an SICU during universial precautions: new epidemiology for nosocomial MRSA. Abstract # 473 Presented at the 30th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois October 21-24, 1990.
  744. Boyce JM, Jackson MM, Pugliese G, et al. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA Technical Panel on Infections Within Hospitals. Infect Control Hosp Epidemiol 1994;15(2):105-15.
  745. Boyce JM, Mermel LA, Zervos MJ, et al. Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1995;16(11):634-7.
  746. Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J, Jr. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16(8):459-77.
  747. Cloney DL, Donowitz LG. Overgrown use for infection control in nurseries and neonatal intensive care units. Am J Dis Child 1986;140(7):680-3.
  748. Pelke S, Ching D, Easa D, Melish ME. Gowning does not affect colonization or infection rates in a neonatal intensive care unit. Arch Pediatr Adolesc Med 1994;148(10):1016-20.
  749. Slaughter S, Hayden MK, Nathan C, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996;125(6):448-56.
  750. Duquette-Petersen L, Francis ME, Dohnalek L, Skinner R, Dudas P. The role of protective clothing in infection prevention in patients undergoing autologous bone marrow transplantation. Oncol Nurs Forum 1999;26(8):1319-24. http://www.ons.org.
  751. Sartori M, La Terra G, Aglietta M, Manzin A, Navino C, Verzetti G. Transmission of hepatitis C via blood splash into conjunctiva. Scand J Infect Dis 1993;25(2):270-1.
  752. Hosoglu S, Celen MK, Akalin S, Geyik MF, Soyoral Y, Kara IH. Transmission of hepatitis C by blood splash into conjunctiva in a nurse. Am J Infect Control 2003;31(8):502-4.
  753. CDC. Update: human immunodeficiency virus infections in health-care workers exposed to blood of infected patients. MMWR Morb Mortal Wkly Rep 1987;36(19):285-9.
  754. Keijman J, Tjhie J, Olde Damink S, Alink M. Unusual nosocomial transmission of Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis 2001;20(11):808-9.
  755. Weaver GH. Value of the face mask and other measures. JAMA 1918;70:76.
  756. Weaver GH. Droplet infection and its prevention by the face mask. J Infect Dis 1919;24:218-30.
  757. Davidson IR, Crisp AJ, Hinwood DC, Whitaker SC, Gregson RH. Eye splashes during invasive vascular procedures. Br J Radiol 1995;68(805):39-41.
  758. Guidance for Industry and FDA Staff - Surgical Masks - Premarket Notification [510(k)] Submissions; Guidance for Industry and FDA. http://www.fda.gov/cdrh/ode/guidance/094.html
  759. National Institute for Occupational Health and Safety - Eye Protection for Infection Control. http://www.cdc.gov/niosh/topics/eye/eyeinfectious. html
  760. Gala CL, Hall CB, Schnabel KC, et al. The use of eye-nose goggles to control nosocomial respiratory syncytial virus infection. Jama 1986;256(19):2706-8.
  761. Agah R, Cherry JD, Garakian AJ, Chapin M. Respiratory syncytial virus (RSV) infection rate in personnel caring for children with RSV infections. Routine isolation procedure vs routine procedure supplemented by use of masks and goggles. Am J Dis Child 1987;141(6):695-7.
  762. Thorburn K, Kerr S, Taylor N, van Saene HK. RSV outbreak in a paediatric intensive care unit. J Hosp Infect 2004;57(3):194-201.
  763. http://a257.g.akamaitech.net/7/257/2422/06jun20041800/edocket.access.g po.gov/2004/04-25183.htm
  764. Occupational Safety & Health Administration - Respiratory Protection. www.osha.gov/dcsp/ote/trng-materials/respirators/respirators.html
  765. Campbell DL, Coffey CC, Lenhart SW. Respiratory protection as a function of respirator fitting characteristics and fit-test accuracy. Aihaj 2001;62(1):36-44.
  766. Lee K, Slavcev A, Nicas M. Respiratory protection against Mycobacterium tuberculosis: quantitative fit test outcomes for five type N95 filtering-facepiece respirators. J Occup Environ Hyg 2004;1(1):22-8.
  767. Coffey CC, Campbell DL, Zhuang Z. Simulated workplace performance of N95 respirators. Am Ind Hyg Assoc J 1999;60(5):618-24.
  768. Coffey CC, Lawrence RB, Zhuang Z, Campbell DL, Jensen PA, Myers WR. Comparison of five methods for fit-testing N95 filtering-facepiece respirators. Appl Occup Environ Hyg 2002;17(10):723-30.
  769. National Personal Protective Technology Laboratory. www.cdc.gov/niosh/npptl/.
  770. McGowan JE, Jr. Nosocomial tuberculosis: new progress in control and prevention. Clin Infect Dis 1995;21(3):489-505.
  771. Jarvis WR. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Am J Infect Control 1995;23(2):146-51.
  772. CDC. Emergency Preparedness & Response. wwwbtcdcgov 2003.
  773. Anderson JD, Bonner M, Scheifele DW, Schneider BC. Lack of nosocomial spread of Varicella in a pediatric hospital with negative pressure ventilated patient rooms. Infect Control 1985;6(3):120-1.
  774. Brunell PA, Wood D. Varicella serological status of healthcare workers as a guide to whom to test or immunize. Infect Control Hosp Epidemiol 1999;20(5):355-7.
  775. Saiman L, LaRussa P, Steinberg SP, et al. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers. Infect Control Hosp Epidemiol 2001;22(5):279-83.
  776. Willy ME, Koziol DE, Fleisher T, et al. Measles immunity in a population of healthcare workers. Infect Control Hosp Epidemiol 1994;15(1):12-7.
  777. Wright LJ, Carlquist JF. Measles immunity in employees of a multihospital healthcare provider. Infect Control Hosp Epidemiol 1994;15(1):8-11.
  778. CDC. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV. MMWR Recomm Rep 2001;50 (RR-11):1-52.
  779. Do AN, Ciesielski CA, Metler RP, Hammett TA, Li J, Fleming PL. Occupationally acquired human immunodeficiency virus (HIV) infection: national case surveillance data during 20 years of the HIV epidemic in the United States. Infect Control Hosp Epidemiol 2003;24(2):86-96.
  780. CDC. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR Morb Mortal Wkly Rep 1988;37(24):377-82, 87-8.
  781. Davis MS. Occupational hazards of operating: opportunities for improvement. Infect Control Hosp Epidemiol 1996;17(10):691-3.
  782. Gerberding JL. Procedure-specific infection control for preventing intraoperative blood exposures. Am J Infect Control 1993;21(6):364-7.
  783. Fry DE, Telford GL, Fecteau DL, Sperling RS, Meyer AA. Prevention of blood exposure. Body and facial protection. Surg Clin North Am 1995;75(6):1141-57.
  784. Hansen ME. Bloodborne pathogens and procedure safety in interventional radiology. Semin Ultrasound CT MR 1998;19(2):209-14.
  785. Holodnick CL, Barkauskas V. Reducing percutaneous injuries in the OR by educational methods. Aorn J 2000;72(3):461-4, 8-72, 75-6.
  786. www.osha.gov/SLTC/bloodbornepathogens/index.html
  787. www.cdc.gov/niosh/2000-108.html
  788. National Insititute for Occupational Health and Safety - Safer Medical Device Implementation in Health Care Facilities. http://www.cdc.gov/niosh/topics/bbp/safer/
  789. www.cdc.gov/sharpssafety/resources.html.
  790. Catanzaro A. Nosocomial tuberculosis. Am Rev Respir Dis 1982;125(5):559-62.
  791. Cepeda JA, Whitehouse T, Cooper B, et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 2005;365(9456):295-304.
  792. Mulin B, Rouget C, Clement C, et al. Association of private isolation rooms with ventilator-associated Acinetobacter baumanii pneumonia in a surgical intensive-care unit. Infect Control Hosp Epidemiol 1997;18(7):499-503.
  793. www.aia.org/aah_gd_hospcons.
  794. Raad I, Abbas J, Whimbey E. Infection control of nosocomial respiratory viral disease in the immunocompromised host. Am J Med 1997;102(3A):48-52; discussion 3-4.
  795. Isaacs D, Dickson H, O'Callaghan C, Sheaves R, Winter A, Moxon ER. Handwashing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus. Arch Dis Child 1991;66(2):227-31.
  796. Chang VT, Nelson K. The role of physical proximity in nosocomial diarrhea. Clin Infect Dis 2000;31(3):717-22.
  797. Byers KE, Anglim AM, Anneski CJ, et al. A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001;22(3):140-7.
  798. Dassut B. The implementation of a commode cleaning and identification system. Nurs Times 2004;100(8):47.
  799. Mayer RA, Geha RC, Helfand MS, Hoyen CK, Salata RA, Donskey CJ. Role of fecal incontinence in contamination of the environment with vancomycin-resistant enterococci. Am J Infect Control 2003;31(4):221-5.
  800. Samore MH, Venkataraman L, DeGirolami PC, Arbeit RD, Karchmer AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996;100(1):3240.
  801. Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992;166(3):561-7.
  802. Samore MH. Epidemiology of nosocomial clostridium difficile diarrhoea. J Hosp Infect 1999;43 Suppl:S183-90.
  803. Tokars JI, Satake S, Rimland D, et al. The prevalence of colonization with vancomycin-resistant Enterococcus at a Veterans' Affairs institution. Infect Control Hosp Epidemiol 1999;20(3):171-5.
  804. Cone R, Mohan K, Thouless M, Corey L. Nosocomial transmission of rotavirus infection. Pediatr Infect Dis J 1988;7(2):103-9.
  805. Bruce BB, Blass MA, Blumberg HM, Lennox JL, del Rio C, Horsburgh CR, Jr. Risk of Cryptosporidium parvum transmission between hospital roommates. Clin Infect Dis 2000;31(4):947-50.
  806. Ford-Jones EL, Mindorff CM, Gold R, Petric M. The incidence of viral-associated diarrhea after admission to a pediatric hospital. Am J Epidemiol 1990;131(4):711-8.
  807. Murray-Leisure KA, Geib S, Graceley D, et al. Control of epidemic methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 1990;11(7):343-50.
  808. Jochimsen EM, Fish L, Manning K, et al. Control of vancomycin-resistant enterococci at a community hospital: efficacy of patient and staff cohorting. Infect Control Hosp Epidemiol 1999;20(2):106-9.
  809. Sample ML, Gravel D, Oxley C, Toye B, Garber G, Ramotar K. An outbreak of vancomycin-resistant enterococci in a hematology-oncology unit: control by patient cohorting and terminal cleaning of the environment. Infect Control Hosp Epidemiol 2002;23(8):468-70.
  810. Podnos YD, Cinat ME, Wilson SE, Cooke J, Gornick W, Thrupp LD. Eradication of multi-drug resistant Acinetobacter from an Intensive Care Unit. Surgical Infections 2001;2(2):297-301.
  811. Graham PL, 3rd, Morel AS, Zhou J, et al. Epidemiology of methicillin-susceptible Staphylococcus aureus in the neonatal intensive care unit. Infect Control Hosp Epidemiol 2002;23(11):677-82.
  812. Doherty JA, Brookfield DS, Gray J, McEwan RA. Cohorting of infants with respiratory syncytial virus. J Hosp Infect 1998;38(3):203-6.
  813. Hall CB, Geiman JM, Douglas RG, Jr., Meagher MP. Control of nosocomial respiratory syncytial viral infections. Pediatrics 1978;62(5):728-32.
  814. Buffington J, Chapman LE, Stobierski MG, et al. Epidemic keratoconjunctivitis in a chronic care facility: risk factors and measures for control. J Am Geriatr Soc 1993;41(11):1177-81.
  815. Grehn M, Kunz J, Sigg P, Slongo R, Zbinden R. Nosocomial rotavirus infections in neonates: means of prevention and control. J Perinat Med 1990;18(5):369-74.
  816. Tan YM, Chow PK, Tan BH, et al. Management of inpatients exposed to an outbreak of severe acute respiratory syndrome (SARS). J Hosp Infect 2004;58(3):210-5.
  817. Talon D, Vichard P, Muller A, Bertin M, Jeunet L, Bertrand X. Modelling the usefulness of a dedicated cohort facility to prevent the dissemination of MRSA. J Hosp Infect 2003;54(1):57-62.
  818. Hotchkiss JR, Strike DG, Simonson DA, Broccard AF, Crooke PS. An agent-based and spatially explicit model of pathogen dissemination in the intensive care unit. Crit Care Med 2005;33(1):168-76; discussion 253-4.
  819. Austin DJ, Bonten MJ, Weinstein RA, Slaughter S, Anderson RM. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci U S A 1999;96(12):6908-13.
  820. Kovner CT, Harrington C. Counting nurses. Data show many nursing homes to be short staffed. Am J Nurs 2000;100(9):53-4.
  821. Mueller C. Staffing problems in long-term care. Let's do something about it! J Gerontol Nurs 2003;29(3):3-4.
  822. Stats & facts. Nursing staff shortages in long-term care facilities. Manag Care Interface 2000;13(11):46-7.
  823. Mejias A, Chavez-Bueno S, Ramilo O. Human metapneumovirus: a not so new virus. Pediatr Infect Dis J 2004;23(1):1-7; quiz 8-10.
  824. Iwane MK, Edwards KM, Szilagyi PG, et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 2004;113(6):1758-64.
  825. Ong GM, Wyatt DE, O'Neill HJ, McCaughey C, Coyle PV. A comparison of nested polymerase chain reaction and immunofluorescence for the diagnosis of respiratory infections in children with bronchiolitis, and the implications for a cohorting strategy. J Hosp Infect 2001;49(2):122-8.
  826. von Linstow ML, Larsen HH, Eugen-Olsen J, et al. Human metapneumovirus and respiratory syncytial virus in hospitalized danish children with acute respiratory tract infection. Scan J Infect Dise 2004;36:578-84.
  827. Gehanno JF, Pestel-Caron M, Nouvellon M, Caillard JF. Nosocomial pertussis in healthcare workers from a pediatric emergency unit in France. Infect Control Hosp Epidemiol 1999;20(8):549-52.
  828. www.cdc.gov/flu/professionals/infectioncontrol/resphygiene.htm.
  829. Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326(23):1514-21.
  830. CDC. Update: Severe Acute Respiratory Syndrome --- Toronto, Canada, 2003. MMWR 2003;52(23):547-50.
  831. Starke JR. Transmission of Mycobacterium tuberculosis to and from children and adolescents. Seminars Pedi Infect Dis 2001;12:115-23.
  832. Saiman L, Macdonald N, Burns JL, Hoiby N, Speert DP, Weber D. Infection control in cystic fibrosis: practical recommendations for the hospital, clinic, and social settings. Am J Infect Control 2000;28(5):3815.( s).
  833. COID. 2003 Report of the Committee on Infectious Diseases. In: Redbook. Elk Grove Village, IL: American Academy of Pediatrics; 2003.
  834. Lau JT, Lau M, Kim JH, Tsui HY, Tsang T, Wong TW. Probable secondary infections in households of SARS patients in Hong Kong. Emerg Infect Dis 2004;10(2):235-43.
  835. Hota B. Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis 2004;39(8):1182-9.
  836. Rutala WA, Weber DJ. Disinfection and sterilization in health care facilities: what clinicians need to know. Clin Infect Dis 2004;39(5):702-9.
  837. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32(5):1148-53.
  838. Engelhart S, Krizek L, Glasmacher A, Fischnaller E, Marklein G, Exner M. Pseudomonas aeruginosa outbreak in a haematology-oncology unit associated with contaminated surface cleaning equipment. J Hosp Infect 2002;52(2):93-8.
  839. Denton M, Wilcox MH, Parnell P, et al. Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. J Hosp Infect 2004;56(2):106-10.
  840. Hollyoak V, Allison D, Summers J. Pseudomonas aeruginosa wound infection associated with a nursing home's whirlpool bath. Commun Dis Rep CDR Rev 1995;5(7):R100-2.
  841. Malik RE, Cooper RA, Griffith CJ. Use of audit tools to evaluate the efficacy of cleaning systems in hospitals. Am J Infect Control 2003;31(3):181-7.
  842. Ansari SA, Springthorpe VS, Sattar SA. Survival and vehicular spread of human rotaviruses: possible relation to seasonality of outbreaks. Rev Infect Dis 1991;13(3):448-61.
  843. Kaatz GW, Gitlin SD, Schaberg DR, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988;127(6):1289-94.
  844. Mayfield JL, Leet T, Miller J, Mundy LM. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 2000;31(4):995-1000.
  845. Dennehy PH. Transmission of rotavirus and other enteric pathogens in the home. Pediatr Infect Dis J 2000;19(10 Suppl):S103-5.
  846. Dennehy P. Rotavirus infections in infection control reference service. In: Abrutyn E, Goldmann D, Scheckler W, eds. Philadelphia: WE Saunders; 2001:821-3.
  847. Wilcox MH, Fawley WN, Wigglesworth N, Parnell P, Verity P, Freeman J. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect 2003;54(2):109-14.
  848. Rutala WA, Weber DJ, Committee HICPA. Guideline for Disinfection and Sterilization in Health-Care Facilities 2007 (in press).
  849. Bernards AT, Harinck HI, Dijkshoorn L, van der Reijden TJ, van den Broek PJ. Persistent Acinetobacter baumannii? Look inside your medical equipment. Infect Control Hosp Epidemiol 2004;25(11):1002-4.
  850. Neely AN, Weber JM, Daviau P, et al. Computer equipment used in patient care within a multihospital system: recommendations for cleaning and disinfection. Am J Infect Control 2005;33(4):233-7.
  851. Neely AN, Maley MP, Warden GD. Computer keyboards as reservoirs for Acinetobacter baumannii in a burn hospital. Clin Infect Dis 1999;29(5):1358-60.
  852. Bures S, Fishbain JT, Uyehara CF, Parker JM, Berg BW. Computer keyboards and faucet handles as reservoirs of nosocomial pathogens in the intensive care unit. Am J Infect Control 2000;28(6):465-71.
  853. Brooks S, Khan A, Stoica D, et al. Reduction in vancomycin-resistant Enterococcus and Clostridium difficile infections following change to tympanic thermometers. Infect Control Hosp Epidemiol 1998;19(5):333-6.
  854. Jernigan JA, Siegman-Igra Y, Guerrant RC, Farr BM. A randomized crossover study of disposable thermometers for prevention of Clostridium difficile and other nosocomial infections. Infect Control Hosp Epidemiol 1998;19(7):494-9.
  855. Weinstein SA, Gantz NM, Pelletier C, Hibert D. Bacterial surface contamination of patients' linen: isolation precautions versus standard care. Am J Infect Control 1989;17(5):264-7.
  856. Pugliese G. Isolating and double-bagging laundry: is it really necessary? Health Facil Manage 1989;2(2):16, 8-21.
  857. . (Accessed 2007, at
  858. Kiehl E, Wallace R, Warren C. Tracking perinatal infection: is it safe to launder your scrubs at home? MCN Am J Matern Child Nurs 1997;22(4):195-7.
  859. Jurkovich P. Home- versus hospital-laundered scrubs: a pilot study. MCN Am J Matern Child Nurs 2004;29(2):106-10.
  860. United States Environmental Protection Agency - Medical Waste. www.epa.gov/epaoswer/other/medical/
  861. www.cdc.gov/ncidod/dhqp/gl_environinfection.html
  862. Maki DG, Alvarado C, Hassemer C. Double-bagging of items from isolation rooms is unnecessary as an infection control measure: a comparative study of surface contamination with single- and double-bagging. Infect Control 1986;7(11):535-7.
  863. CDC. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR Recomm Rep 2005;54(RR-14):1-16.
  864. CDC. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000;49(RR-7):1-10.
  865. CDC. Notice to Readers: Additional options for preventive treatment for persons exposed to inhalational anthrax. MMWR Morb Mortal Wkly Rep 2001;50 (50):1142-51.
  866. CDC. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep 2005;54(RR-9):1-17.
  867. Boyce JM. MRSA patients: proven methods to treat colonization and infection. J Hosp Infect 2001;48 Suppl A:S9-14.
  868. Barrett FF, Mason EO, Jr., Fleming D. Brief clinical and laboratory observations. J Pediatr 1979;94(5):796-800.
  869. American Academy of Pediatrics. Guidelines for Perinatal Care. American Academy of Obstetricians and Gynecologists, 2002. Elk Grove Village, Il; 2002.
  870. Management of Multidrug-Resistant Organisms In Healthcare Settings, 2006. CDC, 2006. (Accessed 2007, at
  871. Kallen AJ, Wilson CT, Larson RJ. Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis. Infect Control Hosp Epidemiol 2005;26(12):916-22.
  872. Carrier M, Marchand R, Auger P, et al. Methicillin-resistant Staphylococcus aureus infection in a cardiac surgical unit. J Thorac Cardiovasc Surg 2002;123(1):40-4.
  873. Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D'Agata EM. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 2003;37(12):1629-38.
  874. CDC. Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 1997;46(RR18):1-42.
  875. Mahoney FJ, Stewart K, Hu H, Coleman P, Alter MJ. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med 1997;157(22):2601-5.
  876. Gladstone JL, Millian SJ. Rubella exposure in an obstetric clinic. Obstet Gynecol 1981;57(2):182-6.
  877. Wilde JA, McMillan JA, Serwint J, Butta J, O'Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA 1999;281(10):908-13.
  878. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997;175(1):1-6.
  879. Pearson ML, Bridges CB, Harper SA. Influenza vaccination of health-care personnel: recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55(RR-2):116.
  880. Wright SW, Decker MD, Edwards KM. Incidence of pertussis infection in healthcare workers. Infect Control Hosp Epidemiol 1999;20(2):120-3.
  881. Calugar A, Ortega-Sanchez IR, Tiwari T, Oakes L, Jahre JA, Murphy TV. Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers. Clin Infect Dis 2006;42(7):981-8.
  882. www.fda.gov
  883. Campins-Marti M, Cheng HK, Forsyth K, et al. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine 2001;20(5-6):641-6.
  884. www.cdc.gov/nip/recs/provisional_recs/default.htm
  885. CDC. Recommended childhood and adolescent immunization schedule -- United States, 2006. MMWR Morb Mortal Wkly Rep 2006;54(Nos. 51 & 52):Q1-Q4.
  886. Recommended childhood and adolescent immunization schedule--United States, 2006. Pediatrics 2006;117(1):239-40.
  887. CDC. Recommended adult immunization schedule -- United States, October 2005-September 2006. MMWR Morb Mortal Wkly Rep 2005;54(40):Q1-Q4; October 14.
  888. CDC. Prevention of Varicella Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999;48 (RR-6):1-5.
  889. McKenney D, Pouliot KL, Wang Y, et al. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science 1999;284(5419):1523-7.
  890. Shinefield H, Black S, Fattom A, et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 2002;346(7):491-6.
  891. Abadesso C, Almeida HI, Virella D, Carreiro MH, Machado MC. Use of palivizumab to control an outbreak of syncytial respiratory virus in a neonatal intensive care unit. J Hosp Infect 2004;58(1):38-41.
  892. George RH, Gully PR, Gill ON, Innes JA, Bakhshi SS, Connolly M. An outbreak of tuberculosis in a children's hospital. J Hosp Infect 1986;8(2):129-42.
  893. Simor AE, Lee M, Vearncombe M, et al. An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect Control Hosp Epidemiol 2002;23(5):261-7.
  894. Puzniak LA, Leet T, Mayfield J, Kollef M, Mundy LM. To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci. Clin Infect Dis 2002;35(1):18-25.
  895. Hanna H, Umphrey J, Tarrand J, Mendoza M, Raad I. Management of an outbreak of vancomycin-resistant enterococci in the medical intensive care unit of a cancer center. Infect Control Hosp Epidemiol 2001;22(4):217-9.
  896. CDC. Recommendations for preventing transmission of infection with human T- lymphotropic virus type III/lymphadenopathy-associated virus in the workplace. MMWR Morb Mortal Wkly Rep 1985;34(450:681-6, 91-5.
  897. CDC. Severe acute respiratory syndrome--Taiwan, 2003. MMWR Morb Mortal Wkly Rep 2003;52(20):461-6.
  898. Capps JA. Measures for the prevention and control of respiratory infections in military camps. JAMA 1918;71:448-51.
  899. Thomas C. Efficiency of surgical masks in use in hospital wards. Report to the Control of Infection Subcommittee. Guys Hosp Rep 1961;110:157-67.
  900. Beck M, Antle BJ, Berlin D, et al. Wearing masks in a pediatric hospital: developing practical guidelines. Can J Public Health 2004;95(4):256-7.
  901. Ryan MA, Christian RS, Wohlrabe J. Handwashing and respiratory illness among young adults in military training. Am J Prev Med 2001;21(2):7983.
  902. Roberts L, Smith W, Jorm L, Patel M, Douglas RM, McGilchrist C. Effect of infection control measures on the frequency of upper respiratory infection in child care: a randomized, controlled trial. Pediatrics 2000;105(4 Pt 1):738-42.js.
  903. White C, Kolble R, Carlson R, et al. The effect of hand hygiene on illness rate among students in university residence halls. Am J Infect Control 2003;31(6):364-70.
  904. Aiello AE, Larson EL. What is the evidence for a causal link between hygiene and infections? Lancet Infect Dis 2002;2(2):103-10.
  905. www.aana.com/news.aspx?ucNavMenu_TSMenuTargetID=171&ucNav Menu_TSMenuTargetType=4&ucNavMenu_TSMenuID=6&id=1613.
  906. Watanakunakorn C, Stahl C. Streptococcus salivarius meningitis following myelography. Infect Control Hosp Epidemiol 1992;13(8):454.
  907. Gelfand MS, Abolnik IZ. Streptococcal meningitis complicating diagnostic myelography: three cases and review. Clin Infect Dis 1995;20(3):582-7.
  908. Schlesinger JJ, Salit IE, McCormack G. Streptococcal meningitis after myelography. Arch Neurol 1982;39(9):576-7.
  909. Yaniv LG, Potasman I. Iatrogenic meningitis: an increasing role for resistant viridans streptococci? Case report and review of the last 20 years. Scand J Infect Dis 2000;32(6):693-6.
  910. Schlegel L, Merlet C, Laroche JM, Fremaux A, Geslin P. Iatrogenic meningitis due to Abiotrophia defectiva after myelography. Clin Infect Dis 1999;28(1):155-6.
  911. Schneeberger PM, Janssen M, Voss A. Alpha-hemolytic streptococci: a major pathogen of iatrogenic meningitis following lumbar puncture. Case reports and a review of the literature. Infection 1996;24(1):29-33.
  912. Veringa E, van Belkum A, Schellekens H. Iatrogenic meningitis by Streptococcus salivarius following lumbar puncture. J Hosp Infect 1995;29(4):316-8.
  913. Couzigou C, Vuong TK, Botherel AH, Aggoune M, Astagneau P. Iatrogenic Streptococcus salivarius meningitis after spinal anaesthesia: need for strict application of standard precautions. J Hosp Infect 2003;53(4):313-4.
  914. Torres E, Alba D, Frank A, Diez-Tejedor E. Iatrogenic meningitis due to Streptococcus salivarius following a spinal tap. Clin Infect Dis 1993;17(3):525-6.
  915. Trautmann M, Lepper PM, Schmitz FJ. Three cases of bacterial meningitis after spinal and epidural anesthesia. Eur J Clin Microbiol Infect Dis 2002;21(1):43-5.
  916. Baer ET. Iatrogenic meningitis: the case for face masks. Clin Infect Dis 2000;31(2):519-21.
  917. Black SR, Weinstein RA. The case for face masks-zorro or zero? Clin Infect Dis 2000;31(2):522-3.
  918. Philips BJ, Fergusson S, Armstrong P, Anderson FM, Wildsmith JA. Surgical face masks are effective in reducing bacterial contamination caused by dispersal from the upper airway. Br J Anaesth 1992;69(4):4078.
  919. CDC. Guidelines for the Prevention of Intravascular Catheter-Related Infections. MMWR 2002;51(RR10)(10):1-26.
  920. Catalano G, Houston SH, Catalano MC, et al. Anxiety and depression in hospitalized patients in resistant organism isolation. South Med J 2003;96(2):141-5.
  921. Tarzi S, Kennedy P, Stone S, Evans M. Methicillin-resistant Staphylococcus aureus: psychological impact of hospitalization and isolation in an older adult population. J Hosp Infect 2001;49(4):250-4.
  922. Kelly-Rossini L, Perlman DC, Mason DJ. The experience of respiratory isolation for HIV-infected persons with tuberculosis. J Assoc Nurses AIDS Care 1996;Jan-Feb; 7(1):29-36.
  923. Knowles HE. The experience of infectious patients in isolation. Nurs Times 1993;89(30):53-6.
  924. Evans HL, Shaffer MM, Hughes MG, et al. Contact isolation in surgical patients: a barrier to care? Surgery 2003;134(2):180-8.
  925. Kirkland KB, Weinstein JM. Adverse effects of contact isolation. Lancet 1999;354(9185):1177-8.
  926. Saint S, Higgins LA, Nallamothu BK, Chenoweth C. Do physicians examine patients in contact isolation less frequently? A brief report. Am J Infect Control 2003;31(6):354-6.
  927. Management of Multidrug-Resistant Organisms In Healthcare Settings, 2006. 2006. www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf
  928. Hall CB, Powell KR, MacDonald NE, et al. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 1986;315(2):77-81.
  929. Lui SL, Luk WK, Cheung CY, Chan TM, Lai KN, Peiris JS. Nosocomial outbreak of parvovirus B19 infection in a renal transplant unit. Transplantation 2001;71(1):59-64.
  930. Weinstock DM, Gubareva LV, Zuccotti G. Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med 2003;348(9):867-8.
  931. van Tol MJ, Claas EC, Heemskerk B, et al. Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity. Bone Marrow Transplant 2005;35 Suppl 1:S73-6.
  932. Wood DJ, David TJ, Chrystie IL, Totterdell B. Chronic enteric virus infection in two T-cell immunodeficient children. J Med Virol 1988;24(4):435-44.
  933. Mori I, Matsumoto K, Sugimoto K, et al. Prolonged shedding of rotavirus in a geriatric inpatient. J Med Virol 2002;67(4):613-5.
  934. Cederna JE, Terpenning MS, Ensberg M, Bradley SF, Kauffman CA. Staphylococcus aureus nasal colonization in a nursing home: eradication with mupirocin. Infect Control Hosp Epidemiol 1990;11(1):13-6.
  935. Kauffman CA, Terpenning MS, He X, et al. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment. Am J Med 1993;94(4):371-8.
  936. Montecalvo MA, de Lencastre H, Carraher M, et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995;16(12):680-5.
  937. D'Agata EM, et al. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis 2002;34(2):167-72.
  938. Donskey CJ, Hoyen CK, Das SM, Helfand MS, Hecker MT. Recurrence of vancomycin-resistant Enterococcus stool colonization during antibiotic therapy. Infect Control Hosp Epidemiol 2002;23(8):436-40.
  939. Scanvic A, Denic L, Gaillon S, Giry P, Andremont A, Lucet JC. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis 2001;32(10):1393-8.
  940. Noskin GA, Bednarz P, Suriano T, Reiner S, Peterson LR. Persistent contamination of fabric-covered furniture by vancomycin-resistant enterococci: implications for upholstery selection in hospitals. Am J Infect Control 2000;28(4):311-3.
  941. Gerson SL, Parker P, Jacobs MR, Creger R, Lazarus HM. Aspergillosis due to carpet contamination. Infect Control Hosp Epidemiol 1994;15(4 Pt 1):221-3.
  942. Taplin D, Mertz PM. Flower vases in hospitals as reservoirs of pathogens. Lancet 1973;2(7841):1279-81.
  943. Walsh TJ, Dixon DM. Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment. Eur J Epidemiol 1989;5(2):131-42.
  944. Lass-Florl C, Rath P, Niederwieser D, et al. Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants. J Hosp Infect 2000;46(1):31-5.
  945. Raad I, Hanna H, Osting C, et al. Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during construction. Infect Control Hosp Epidemiol 2002;23(1):41-3.
  946. www.cms.hhs.gov/CLIA.
  947. Emori TG, Haley RW, Stanley RC. The infection control nurse in US hospitals, 1976-1977. Characteristics of the position and its occupant. Am J Epidemiol 1980;111(5):592-607.
  948. Richet HM, Benbachir M, Brown DE, et al. Are there regional variations in the diagnosis, surveillance, and control of methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 2003;24(5):33441.
  949. Anderson DJ, Kirkland KB, McDonald JR, et al. Results of a survey of work duties of 56 infection control professionals (ICPs): Are new guidelines needed for the staffing of infection control (IC) programs? Abstract #146. In: 16th Annual Society for Healthcare Epidemiology of America. Chicago, Ill; 2006.
  950. Harvey MA. Critical-care-unit bedside design and furnishing: impact on nosocomial infections. Infect Control Hosp Epidemiol 1998;19(8):597601.
  951. Srinivasan A, Beck C, Buckley T, et al. The ability of hospital ventilation systems to filter Aspergillus and other fungi following a building implosion. Infect Control Hosp Epidemiol 2002;23(9):520-4.
  952. Maragakis LL, Bradley KL, Song X, et al. Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol 2006;27(1):67-70.
  953. Organizations JCoAoH. Comprehensive Accredication Manual for Hospitals: The Official Handbook. Oakbrook Terrace: JCAHO; 2007.
  954. Peterson LR, Noskin GA. New technology for detecting multidrugresistant pathogens in the clinical microbiology laboratory. Emerg Infect Dis 2001;7(2):306-11.
  955. Diekema DJ, Doebbeling BN. Employee health and infection control. Infect Control Hosp Epidemiol 1995;16(5):292-301.
  956. Rutala WA, Weber DJ, Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for Disinfection and Sterilization in Health-Care Facilities. In preparation.
  957. Weems JJ, Jr. Nosocomial outbreak of Pseudomonas cepacia associated with contamination of reusable electronic ventilator temperature probes. Infect Control Hosp Epidemiol 1993;14(10):583-6.
  958. Berthelot P, Grattard F, Mahul P, et al. Ventilator temperature sensors: an unusual source of Pseudomonas cepacia in nosocomial infection. J Hosp Infect 1993;25(1):33-43.
  959. CDC. Bronchoscopy-related infections and pseudoinfections--New York, 1996 and 1998. MMWR Morb Mortal Wkly Rep 1999;48(26):55760.
  960. Heeg P, Roth K, Reichl R, Cogdill CP, Bond WW. Decontaminated single-use devices: an oxymoron that may be placing patients at risk for cross-contamination. Infect Control Hosp Epidemiol 2001;22(9):542-9.
  961. www.fda.gov/cdrh/reprocessing/
  962. CDC. Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR - Morbidity & Mortality Weekly Report 2003;52(RR08):1-36.
  963. Weinstock DM, Eagan J, Malak SA, et al. Control of influenza A on a bone marrow transplant unit. Infect Control Hosp Epidemiol 2000;21(11):730-2.
  964. Cromer AL, Hutsell SO, Latham SC, et al. Impact of implementing a method of feedback and accountability related to contact precautions compliance. Am J Infect Control 2004;32(8):451-5.
  965. Eveillard M, Eb F, Tramier B, et al. Evaluation of the contribution of isolation precautions in prevention and control of multi-resistant bacteria in a teaching hospital. J Hosp Infect 2001;47(2):116-24.
  966. Pfeiffer J, Gilmore G. The Text as an Orientation Tool. In: Pfeiffer J, ed. APIC Text of Infection Control and Epidemiology. Washingto, DC: Association for Professionals in Infection Control and Epidemiology, Inc. (APIC); 2000:7/1 - 7/8.
  967. Gaynes RP, Emori TG. Chapter 5: Surveillance for Nosocomial Infections. In: Abrutyn E, Goldmann DA, Scheckler WE, eds. Saunders Infection Control Reference Service. Philadelphia, PA: W.B. Saunders Company; 2001:40-4.
  968. CDC. Monitoring hospital-acquired infections to promote patient safety-United States, 1990-1999. MMWR Morb Mortal Wkly Rep 2000;49(8):149-53.
  969. Curran ET, Benneyan JC, Hood J. Controlling methicillin-resistant Staphylococcus aureus: a feedback approach using annotated statistical process control charts. Infect Control Hosp Epidemiol 2002;23(1):13-8.
  970. Lanotte P, Cantagrel S, Mereghetti L, et al. Spread of Stenotrophomonas maltophilia colonization in a pediatric intensive care unit detected by monitoring tracheal bacterial carriage and molecular typing. Clin Microbiol Infect 2003;9(11):1142-7.
  971. Coopersmith CM, Zack JE, Ward MR, et al. The impact of bedside behavior on catheter-related bacteremia in the intensive care unit. Arch Surg 2004;139(2):131-6.
  972. O'Brien KL, Beall B, Barrett NL, et al. Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002;35(3):268-76.
  973. Nicolle LE, Dyck B, Thompson G, et al. Regional dissemination and control of epidemic methicillin-resistant Staphylococcus aureus. Manitoba Chapter of CHICA-Canada. Infect Control Hosp Epidemiol 1999;20(3):202-5.
  974. Seybold U, Kourbatova EV, Johnson JG, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006;42(5):647-56.
  975. Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE. Survival of hepatitis B virus after drying and storage for one week. Lancet 1981;1(8219):550-1.
  976. Ehrenkranz NJ, Alfonso BC. Failure of bland soap handwash to prevent hand transfer of patient bacteria to urethral catheters. Infect Control Hosp Epidemiol 1991;12(11):654-62.
  977. Winnefeld M, Richard MA, Drancourt M, Grob JJ. Skin tolerance and effectiveness of two hand decontamination procedures in everyday hospital use. Br J Dermatol 2000;143(3):546-50.
  978. Widmer AF. Replace hand washing with use of a waterless alcohol hand rub? Clin Infect Dis 2000;31(1):136-43.
  979. Mortimer EA, Jr., Lipsitz PJ, Wolinsky E, Gonzaga AJ, Rammelkamp CH, Jr. Transmission of staphylococci between newborns. Importance of the hands to personnel. Am J Dis Child 1962;104:289-95.
  980. Casewell M, Phillips I. Hands as route of transmission for Klebsiella species. Br Med J 1977;2(6098):1315-7.
  981. Ojajarvi J. Effectiveness of hand washing and disinfection methods in removing transient bacteria after patient nursing. J Hyg (Lond) 1980;85(2):193-203.
  982. Otter J, Havill N, Adams N, Joyce J. Extensive environmental contamination associated with patients with loose stools and MRSA colonization of the gastrointestinal tract. Abstract #159. In: the 16th annual scientific meeting of the Society for Healthcare Epidemiology of America. In. Chicago, Illinois; 2006.
  983. Weber DJ, Sickbert-Bennett E, Gergen MF, Rutala WA. Efficacy of selected hand hygiene agents used to remove Bacillus atrophaeus (a surrogate of Bacillus anthracis) from contaminated hands. Jama 2003;289(10):1274-7.
  984. Saiman L, Lerner A, Saal L, et al. Banning artificial nails from health care settings. Am J Infect Control 2002;30(4):252-4.
  985. Johnson S, Gerding DN, Olson MM, et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 1990;88(2):137-40.
  986. Neal JG, Jackson EM, Suber F, Edlich RF. Latex glove penetration by pathogens: a review of the literature. J Long Term Eff Med Implants 1998;8(3-4):233-40.
  987. Broyles JM, O'Connell KP, Korniewicz DM. PCR-based method for detecting viral penetration of medical exam gloves. J Clin Microbiol 2002;40(8):2725-8.
  988. Patterson JE, Vecchio J, Pantelick EL, et al. Association of contaminated gloves with transmission of Acinetobacter calcoaceticus var. anitratus in an intensive care unit. Am J Med 1991;91(5):479-83.
  989. Goldmann DA. Epidemiology and prevention of pediatric viral respiratory infections in health-care institutions. Emerg Infect Dis 2001;7(2):249-53.
  990. Gaggero A, Avendano LF, Fernandez J, Spencer E. Nosocomial transmission of rotavirus from patients admitted with diarrhea. J Clin Microbiol 1992;30(12):3294-7.
  991. Merritt K, Hitchins VM, Brown SA. Safety and cleaning of medical materials and devices. J Biomed Mater Res 2000;53(2):131-6.
  992. Kampf G, Bloss R, Martiny H. Surface fixation of dried blood by glutaraldehyde and peracetic acid. J Hosp Infect 2004;57(2):139-43.
  993. Weber DJ, Rutala WA. Role of environmental contamination in the transmission of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1997;18(5):306-9.
  994. Byers KE, Durbin LJ, Simonton BM, Anglim AM, Adal KA, Farr BM. Disinfection of hospital rooms contaminated with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1998;19(4):261-4.
  995. Martinez JA, Ruthazer R, Hansjosten K, Barefoot L, Snydman DR. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Arch Intern Med 2003;163(16):1905-12.
  996. EPA. Federal Insecticide, Fungicide, and Rodenticidal Act 7 U.S.C. 136 et seq. In: Agency EP, ed.
  997. Devine J, Cooke RP, Wright EP. Is methicillin-resistant Staphylococcus aureus (MRSA) contamination of ward-based computer terminals a surrogate marker for nosocomial MRSA transmission and handwashing compliance? J Hosp Infect 2001;48(1):72-5.
  998. Sattar SA, Springthorpe S, Mani S, et al. Transfer of bacteria from fabrics to hands and other fabrics: development and application of a quantitative method using Staphylococcus aureus as a model. J Appl Microbiol 2001;90(6):962-70.
  999. Shiomori T, Miyamoto H, Makishima K, et al. Evaluation of bedmakingrelated airborne and surface methicillin-resistant Staphylococcus aureus contamination. J Hosp Infect 2002;50(1):30-5.
  1000. Whyte W, Baird G, Annand R. Bacterial contamination on the surface of hospital linen chutes. J Hyg (Lond) 1969;67(3):427-35.
  1001. Michaelsen GS. Designing Linen Chutes to Reduce Spread of Infectious Organisms. Hospitals 1965;39:116-9.
  1002. Plott RT, Wagner RF, Jr., Tyring SK. Iatrogenic contamination of multidose vials in simulated use. A reassessment of current patient injection technique. Arch Dermatol 1990;126(11):1441-4.
  1003. Samandari T, Malakmadze N, Balter S, et al. A large outbreak of hepatitis B virus infections associated with frequent injections at a physician's office. Infect Control Hosp Epidemiol 2005;26(9):745-50.
  1004. Comstock RD, Mallonee S, Fox JL, et al. A large nosocomial outbreak of hepatitis C and hepatitis B among patients receiving pain remediation treatments. Infect Control Hosp Epidemiol 2004;25(7):576-83.
  1005. Germain JM, Carbonne A, Thiers V, et al. Patient-to-patient transmission of hepatitis C virus through the use of multidose vials during general anesthesia. Infect Control Hosp Epidemiol 2005;26(9):789-92.
  1006. Macedo de Oliveira A, White KL, Leschinsky DP, et al. An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic. Ann Intern Med 2005;142(11):898-902.
  1007. Hsu J, Jensen B, Arduino M, et al. Streptococcal Meningitis Following Myelogram Procedures. Infect Control Hosp Epidemiol 2007;28(5):61417.
  1008. Srinivasan A, Song X, Ross T, Merz W, Brower R, Perl TM. A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit. Infect Control Hosp Epidemiol 2002;23(8):424-8.
  1009. Nichols WG, Corey L, Gooley T, Davis C, Boeckh M. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 2001;98(3):573-8.
  1010. Elizaga J, Olavarria E, Apperley J, Goldman J, Ward K. Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment. Clin Infect Dis 2001;32(3):413-8.
  1011. Oishi I, Kimura T, Murakami T, et al. Serial observations of chronic rotavirus infection in an immunodeficient child. Microbiology and Immunology 1991;35(11):953-61.
  1012. Fierobe L, Lucet JC, Decre D, et al. An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients. Infect Control Hosp Epidemiol 2001;22(1):35-40.
  1013. Montesinos I, Salido E, Delgado T, Lecuona M, Sierra A. Epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital in the Canary Islands. Infect Control Hosp Epidemiol 2003;24(9):667-72.
  1014. Poutanen SM, Vearncombe M, McGeer AJ, Gardam M, Large G, Simor AE. Nosocomial acquisition of methicillin-resistant Staphylococcus aureus during an outbreak of severe acute respiratory syndrome. Infect Control Hosp Epidemiol 2005;26(2):134-7.
  1015. Yap FH, Gomersall CD, Fung KS, et al. Increase in methicillin-resistant Staphylococcus aureus acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome. Clin Infect Dis 2004;39(4):511-6.
  1016. Layton MC, Perez M, Heald P, Patterson JE. An outbreak of mupirocinresistant Staphylococcus aureus on a dermatology ward associated with an environmental reservoir. Infect Control Hosp Epidemiol 1993;14(7):36975.
  1017. Gilmore A, Stuart J, Andrews N. Risk of secondary meningococcal disease in health-care workers. Lancet 2000;356(9242):1654-5.
  1018. www.cdc.gov/flu/avian/index.htm
  1019. www.hhs.gov/pandemicflu/plan/pdf/S04.pdf
  1020. Ehresmann KR, Hedberg CW, Grimm MB, Norton CA, MacDonald KL, Osterholm MT. An outbreak of measles at an international sporting event with airborne transmission in a domed stadium. J Infect Dis 1995;171(3):679-83.
  1021. Gustafson TL, Lavely GB, Brawner ER, Jr., Hutcheson RH, Jr., Wright PF, Schaffner W. An outbreak of airborne nosocomial varicella. Pediatrics 1982;70(4):550-6.
  1022. Hyams PJ, Stuewe MC, Heitzer V. Herpes zoster causing varicella (chickenpox) in hospital employees: cost of a casual attitude. Am J Infect Control 1984;12(1):2-5.
  1023. Pavelchak N, DePersis RP, London M, et al. Identification of factors that disrupt negative air pressurization of respiratory isolation rooms. Infect Control Hosp Epidemiol 2000;21(3):191-5.
  1024. Rice N, Streifel A, Vesley D. An evaluation of hospital specialventilation- room pressures. Infect Control Hosp Epidemiol 2001;22(1):1923.
  1025. Hutton MD, Stead WW, Cauthen GM, Bloch AB, Ewing WM. Nosocomial transmission of tuberculosis associated with a draining abscess. J Infect Dis 1990;161(2):286-95.
  1026. Frampton MW. An outbreak of tuberculosis among hospital personnel caring for a patient with a skin ulcer. Ann Intern Med 1992;117(4):312-3.
  1027. Ammari LK, Bell LM, Hodinka RL. Secondary measles vaccine failure in healthcare workers exposed to infected patients. Infect Control Hosp Epidemiol 1993;14(2):81-6.
  1028. Behrman A, Schmid DS, Crivaro A, Watson B. A cluster of primary varicella cases among healthcare workers with false-positive varicella zoster virus titers. Infect Control Hosp Epidemiol 2003;24(3):202-6.
  1029. Josephson A, Gombert ME. Airborne transmission of nosocomial varicella from localized zoster. J Infect Dis 1988;158(1):238-41.
  1030. Brodkin RH. Zoster Causing Varicella. Current Dangers Of Contagion Without Isolation. Arch Dermatol 1963;88:322-4.
  1031. Suzuki K, Yoshikawa T, Tomitaka A, Matsunaga K, Asano Y. Detection of aerosolized varicella-zoster virus DNA in patients with localized herpes zoster. J Infect Dis 2004;189(6):1009-12.
  1032. Ruuskanen O, Salmi TT, Halonen P. Measles vaccination after exposure to natural measles. J Pediatr 1978;93(1):43-6.
  1033. Berkovich S, Starr S. Use of live-measles-virus vaccine to abort an expected outbreak of measles within a closed population. N Engl J Med 1963;269:75-7.
  1034. CDC. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1998;47(RR-8):157.
  1035. CDC. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2006;55(RR-15):1-48.
  1036. Watson B, Seward J, Yang A, et al. Postexposure effectiveness of varicella vaccine. Pediatrics 2000;105(1 Pt 1):84-8.
  1037. Salzman MB, Garcia C. Postexposure varicella vaccination in siblings of children with active varicella. Pediatr Infect Dis J 1998;17(3):256-7.
  1038. CDC. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep 2001;50(RR-10):1-25; quiz CE1-7.
  1039. Fulginiti VA, Papier A, Lane JM, Neff JM, Henderson DA. Smallpox vaccination: a review, part I. Background, vaccination technique, normal vaccination and revaccination, and expected normal reactions. Clin Infect Dis 2003;37(2):241-50.
  1040. Dixon CW. Smallpox in Tripolitania, 1946: an epidemiological and clinical study of 500 cases, including trials of penicillin treatment. . J Hyg (Lond) 1948;46:351-77.
  1041. Murray WA, Streifel AJ, O'Dea TJ, Rhame FS. Ventilation for protection of immune compromised patients. ASHRAE Transactions 1988;94:1185.
  1042. Rutala WA, Jones SM, Worthington JM, Reist PC, Weber DJ. Efficacy of portable filtration units in reducing aerosolized particles in the size range of Mycobacterium tuberculosis. Infect Control Hosp Epidemiol 1995;16(7):391-8.
  1043. Mandell GL, Bennett JE, Dolin R. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. GL Mandell, JE Bennett, R Dolin, Eds. 5th edition. Churchill Livingstone, Philadelphia, 2000. 2000.
  1044. Control of Communicable Diseases Manual. DL Heymann Ed. 18th edition, American Public Health Association, Washington, DC 2005. 2005.
  1045. Vreden SG, Visser LG, Verweij JJ, et al. Outbreak of amebiasis in a family in The Netherlands. Clin Infect Dis 2000;31(4):1101-4.
  1046. Thacker SB, Kimball AM, Wolfe M, Choi K, Gilmore L. Parasitic disease control in a residential facility for the mentally retarded: failure of selected isolation procedures. Am J Public Health 1981;71(3):303-5.
  1047. Sampathkumar P. West Nile virus: epidemiology, clinical presentation, diagnosis, and prevention. Mayo Clin Proc 2003;78(9):1137-43; quiz 44.
  1048. Ruben B, Band JD, Wong P, Colville J. Person-to-person transmission of Brucella melitensis. Lancet 1991;337(8732):14-5.
  1049. Vandercam B, Zech F, de Cooman S, Bughin C, Gigi J, Wauters G. Isolation of Brucella melitensis from human sperm. Eur J Clin Microbiol Infect Dis 1990;9(4):303-4.
  1050. Robichaud S, Libman M, Behr M, Rubin E. Prevention of laboratory-acquired brucellosis. Clin Infect Dis 2004;38(12):e119-22.
  1051. Troy CJ, Peeling RW, Ellis AG, et al. Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes. Jama 1997;277(15):1214-8.
  1052. Ekman MR, Grayston JT, Visakorpi R, Kleemola M, Kuo CC, Saikku P. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis 1993;17(3):420-5.
  1053. Eickhoff TC. An outbreak of surgical wound infections due to Clostridium perfringens. Surg Gynecol Obstet 1962;114:102-8.
  1054. Kohn GJ, Linne SR, Smith CM, Hoeprich PD. Acquisition of coccidioidomycosis at necropsy by inhalation of coccidioidal endospores. Diagn Microbiol Infect Dis 1992;15(6):527-30.
  1055. Wright PW, Pappagianis D, Wilson M, et al. Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis 2003;37(9):1265-9.
  1056. Maitreyi RS, Dar L, Muthukumar A, et al. Acute hemorrhagic conjunctivitis due to enterovirus 70 in India. Emerg Infect Dis 1999;5(2):267-9.
  1057. CDC. Acute hemorrhagic conjunctivitis outbreak caused by Coxsackievirus A24--Puerto Rico, 2003. MMWR Morb Mortal Wkly Rep 2004;53(28):632-4.
  1058. Faden H, Wynn RJ, Campagna L, Ryan RM. Outbreak of adenovirus type 30 in a neonatal intensive care unit. J Pediatr 2005;146(4):523-7.
  1059. Chaberny IE, Schnitzler P, Geiss HK, Wendt C. An outbreak of epidemic keratoconjunctivtis in a pediatric unit due to adenovirus type 8. Infect Control Hosp Epidemiol 2003;24(7):514-9.
  1060. Warren D, Nelson KE, Farrar JA, et al. A large outbreak of epidemic keratoconjunctivitis: problems in controlling nosocomial spread. J Infect Dis 1989;160(6):938-43.
  1061. www.cdc.gov/ncidod/dvrd/cjd/qa_cjd_infection_control.htm
  1062. Wang CY, Wu HD, Hsueh PR. Nosocomial transmission of cryptococcosis. N Engl J Med 2005;352(12):1271-2.
  1063. Beyt BE, Jr., Waltman SR. Cryptococcal endophthalmitis after corneal transplantation. N Engl J Med 1978;298(15):825-6.
  1064. Widdowson MA, Glass R, Monroe S, et al. Probable transmission of norovirus on an airplane. Jama 2005;293(15):1859-60.
  1065. CDC. Prevention of Hepatitis A Through Active or Passive Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999;48(RR-12):1-37.
  1066. Rosenblum LS, Villarino ME, Nainan OV, et al. Hepatitis A outbreak in a neonatal intensive care unit: risk factors for transmission and evidence of prolonged viral excretion among preterm infants. J Infect Dis 1991;164(3):476-82.
  1067. Carl M, Kantor RJ, Webster HM, Fields HA, Maynard JE. Excretion of hepatitis A virus in the stools of hospitalized hepatitis patients. J Med Virol 1982;9(2):125-9.
  1068. Robson SC, Adams S, Brink N, Woodruff B, Bradley D. Hospital outbreak of hepatitis E. Lancet 1992;339(8806):1424-5.
  1069. Arvin A, Whitley R. Herpes Simplex virus infections in Infectious Diseases of the Fetus and Newborn Infant, ed. Remington JS and Klein JO. Fifth Edition. WB Saunders Co., Philadelphia, PA. 2001.
  1070. Enright AM, Prober CG. Neonatal herpes infection: diagnosis, treatment and prevention. Semin Neonatol 2002;7(4):283-91.
  1071. Esper F, Boucher D, Weibel C, Martinello RA, Kahn JS. Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children. Pediatrics 2003;111(6 Pt 1):1407-10.
  1072. Colodner R, Sakran W, Miron D, Teitler N, Khavalevsky E, Kopelowitz J. Listeria moncytogenes cross-contamination in a nursery. Am J Infect Control 2003;31(5):322-4.
  1073. Farber JM, Peterkin PI, Carter AO, Varughese PV, Ashton FE, Ewan EP. Neonatal listeriosis due to cross-infection confirmed by isoenzyme typing and DNA fingerprinting. J Infect Dis 1991;163(4):927-8.
  1074. Schuchat A, Lizano C, Broome CV, Swaminathan B, Kim C, Winn K. Outbreak of neonatal listeriosis associated with mineral oil. Pediatr Infect Dis J 1991;10(3):183-9.
  1075. Pejaver RK, Watson AH, Mucklow ES. Neonatal cross-infection with Listeria monocytogenes. J Infect 1993;26(3):301-3.
  1076. Jain SK, Persaud D, Perl TM, et al. Nosocomial malaria and saline flush. Emerg Infect Dis 2005;11(7):1097-9.
  1077. Abulrahi HA, Bohlega EA, Fontaine RE, al-Seghayer SM, al-Ruwais AA. Plasmodium falciparum malaria transmitted in hospital through heparin locks. Lancet 1997;349(9044):23-5.
  1078. Al-Saigul AM, Fontaine RE, Haddad Q. Nosocomial malaria from contamination of a multidose heparin container with blood. Infect Control Hosp Epidemiol 2000;21(5):329-30.
  1079. Piro S, Sammud M, Badi S, Al Ssabi L. Hospital-acquired malaria transmitted by contaminated gloves. J Hosp Infect 2001;47(2):156-8.
  1080. Book LS, Overall JC, Jr., Herbst JJ, Britt MR, Epstein B, Jung AL. Clustering of necrotizing enterocolitis. Interruption by infection-control measures. N Engl J Med 1977;297(18):984-6.
  1081. Rotbart HA, Levin MJ. How contagious is necrotizing enterocolitis? Pediatr Infect Dis 1983;2(5):406-13.
  1082. Rotbart HA, Levin MJ, Yolken RH, Manchester DK, Jantzen J. An outbreak of rotavirus-associated neonatal necrotizing enterocolitis. J Pediatr 1983;103(3):454-9.
  1083. Gerber AR, Hopkins RS, Lauer BA, Curry-Kane AG, Rotbart HA. Increased risk of illness among nursery staff caring for neonates with necrotizing enterocolitis. Pediatr Infect Dis 1985;4(3):246-9.
  1084. Sanchez MP, Erdman DD, Torok TJ, Freeman CJ, Matyas BT. Outbreak of adenovirus 35 pneumonia among adult residents and staff of a chronic care psychiatric facility. J Infect Dis 1997;176(3):760-3.(s).
  1085. Singh-Naz N, Brown M, Ganeshananthan M. Nosocomial adenovirus infection: molecular epidemiology of an outbreak. Pediatr Infect Dis J 1993;12(11):922-5.
  1086. Uemura T, Kawashitam T, Ostuka Y, Tanaka Y, Kusubae R, Yoshinaga M. A recent outbreak of adenovirus type 7 infection in a chronic inpatient facility for the severely handicapped. Infect Control Hosp Epidemiol 2000;21(9):559-60.
  1087. Nuorti JP, Butler JC, Crutcher JM, et al. An outbreak of multidrugresistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med 1998;338(26):1861-8.
  1088. Houff SA, Burton RC, Wilson RW, et al. Human-to-human transmission of rabies virus by corneal transplant. N Engl J Med 1979;300(11):603-4.
  1089. CDC. Human Rabies Prevention - United States, 1999 Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48 (RR-1):1-21.
  1090. Hayden FG. Rhinovirus and the lower respiratory tract. Rev Med Virol 2004;14(1):17-31.
  1091. Valenti WM, Clarke TA, Hall CB, Menegus MA, Shapiro DL. Concurrent outbreaks of rhinovirus and respiratory syncytial virus in an intensive care nursery: epidemiology and associated risk factors. J Pediatr 1982;100(5):722-6.
  1092. Chidekel AS, Rosen CL, Bazzy AR. Rhinovirus infection associated with serious lower respiratory illness in patients with bronchopulmonary dysplasia. Pediatr Infect Dis J 1997;16(1):43-7.
  1093. Drusin LM, Ross BG, Rhodes KH, Krauss AN, Scott RA. Nosocomial ringworm in a neonatal intensive care unit: a nurse and her cat. Infect Control Hosp Epidemiol 2000;21(9):605-7.
  1094. Lewis SM, Lewis BG. Nosocomial transmission of Trichophyton tonsurans tinea corporis in a rehabilitation hospital. Infect Control Hosp Epidemiol 1997;18(5):322-5.
  1095. Saiman L, Jakob K, Holmes KW, et al. Molecular epidemiology of staphylococcal scalded skin syndrome in premature infants. Pediatr Infect Dis J 1998;17(4):329-34.
  1096. Ramage L, Green K, Pyskir D, Simor AE. An outbreak of fatal nosocomial infections due to group A streptococcus on a medical ward. Infect Control Hosp Epidemiol 1996;17(7):429-31.
  1097. Kakis A, Gibbs L, Eguia J, et al. An outbreak of group A Streptococcal infection among health care workers. Clin Infect Dis 2002;35(11):1353-9.
  1098. Schwartz B, Elliott JA, Butler JC, et al. Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings. Clin Infect Dis 1992;15(2):277-84.
  1099. National Communicable Disease Center. Isolation Techniques for Use in Hospitals. 1st ed. Washington, DC: US Government Printing Office;. PHS publication no 2054 1970.
  1100. CDC. Isolation Techniques for Use in Hospitals. 2nd ed. Washington, DC: US Government Printing Office;1975. HHS publication no. (CDC) 80-8314. 1975.
  1101. Garner JS, Simmons BP. CDC Guideline for Isolation Precautions in Hospitals. Atlanta, GA: US Department of Health and Human Services, Public Health Service, Centers for Disease Control; 1983. HHS publication no. (CDC) 83-8314. Infect Control 1983;4:245-325.
  1102. Lynch P, Jackson MM, Cummings MJ, Stamm WE. Rethinking the role of isolation practices in the prevention of nosocomial infections. Ann Intern Med 1987;107(2):243-6.
 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #